"SYMBOL","COMPANY NAME","SUBJECT","DETAILS","BROADCAST DATE/TIME","RECEIPT","DISSEMINATION","DIFFERENCE","ATTACHMENT"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Transcript of Q3Fy24 earnings call held on February 10, 2024.","16-Feb-2024 17:04:36","2024-02-16 17:04:36","16-Feb-2024 17:04:42","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_16022024170436_Q3FY24Earnings_Call_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","12-Feb-2024 14:20:06","2024-02-12 14:20:06","12-Feb-2024 14:20:19","00:00:13","https://nsearchives.nseindia.com/corporate/DIVISLAB_12022024142006_Newspaper_clippings_Q3FY24results.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Link of Recording of Q3FY24 earnings call held on February 10, 2024","10-Feb-2024 16:07:16","2024-02-10 16:07:16","10-Feb-2024 16:07:23","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_10022024160716_Concall_Recording_Q3FY24_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","DIVI'S LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","10-Feb-2024 13:22:00","2024-02-10 13:22:00","10-Feb-2024 13:22:05","00:00:05","https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_10022024132200_CIM_19248_1051024_10022024012200_WEB.xml"
"DIVISLAB","Divi's Laboratories Limited","Change in Director(s)","Divi's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.","10-Feb-2024 12:35:12","2024-02-10 12:35:12","10-Feb-2024 12:35:19","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_10022024123512_BMOutcome_10022024_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on February 10, 2024.","10-Feb-2024 12:11:06","2024-02-10 12:11:06","10-Feb-2024 12:11:12","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_10022024121106_BMOutcome_10022024_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023.","10-Feb-2024 12:06:42","2024-02-10 12:06:42","10-Feb-2024 12:06:49","00:00:07","https://nsearchives.nseindia.com/corporate/FinancialResults_Q3FY24_10022024_10022024120642.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Schedule of meet","02-Feb-2024 16:47:11","2024-02-02 16:47:11","02-Feb-2024 16:47:19","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_02022024164711_ConcallintimationQ3FY24_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Board Meeting Intimation","DIVI'S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .","30-Jan-2024 14:45:52","2024-01-30 14:45:52","30-Jan-2024 14:45:58","00:00:06","https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_30012024144552_PRIOR_INTIMATION_17583_1038759_30012024024551_WEB.xml"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","09-Jan-2024 08:35:07","2024-01-09 08:35:07","09-Jan-2024 08:35:12","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_09012024083507_Reg74_5_Divis31122023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Update on GST Order'.","03-Jan-2024 14:55:56","2024-01-03 14:55:56","03-Jan-2024 14:56:00","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_03012024145556_Intimation_update_on_GST_Order_03012024.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window-XBRL","DIVI'S LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window","30-Dec-2023 08:41:52","2023-12-30 08:41:52","30-Dec-2023 08:41:56","00:00:04","https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_30122023084152_CLOSURE_TRADING_WINDOW_1005319_30122023084151_WEB.xml"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","30-Dec-2023 08:26:34","2023-12-30 08:26:34","30-Dec-2023 08:26:38","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_30122023082634_Intimation_TradingWindowClosure_Q3FY24.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.","25-Dec-2023 11:52:07","2023-12-25 11:52:07","25-Dec-2023 11:52:13","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_25122023115207_Intimation_Regulation30_25122023_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 '.","16-Nov-2023 11:15:58","2023-11-16 11:15:58","16-Nov-2023 11:16:04","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_16112023111558_Regulation30_intimation_16112023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Transcript","11-Nov-2023 08:43:34","2023-11-11 08:43:34","11-Nov-2023 08:43:41","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_11112023084334_Transcript_Q2FY24concall_06112023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","07-Nov-2023 12:42:10","2023-11-07 12:42:10","07-Nov-2023 12:42:25","00:00:15","https://nsearchives.nseindia.com/corporate/DIVISLAB_07112023124211_Newspaper_publication.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Link of Recording","06-Nov-2023 17:14:45","2023-11-06 17:14:45","06-Nov-2023 17:14:51","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_06112023171445_Concall_Recording_Q2FY24.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on November 06, 2023.","06-Nov-2023 12:29:36","2023-11-06 12:29:36","06-Nov-2023 12:29:42","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_06112023122936_OutcomeofBoardMeeting_Q2FY24Results.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2023.","06-Nov-2023 12:27:43","2023-11-06 12:27:43","06-Nov-2023 12:27:48","00:00:05","https://nsearchives.nseindia.com/corporate/OutcomeofBoardMeeting_Q2FY24Results_06112023122743.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Schedule of Earnings call for Q2FY24.","28-Oct-2023 15:16:32","2023-10-28 15:16:32","28-Oct-2023 15:16:37","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_28102023151632_Intimation_Earnings_Call_Q2FY24_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","10-Oct-2023 16:20:44","2023-10-10 16:20:44","10-Oct-2023 16:20:49","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_10102023162044_Reg74_5_Divis30092023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","30-Sep-2023 10:27:49","2023-09-30 10:27:49","30-Sep-2023 10:27:56","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_30092023102749_Intimation_TradingWindowClosure_Q2.pdf"
"DIVISLAB","Divi's Laboratories Limited","Press Release (Revised)","Divi's Laboratories Limited has informed the Exchange regarding a revised press release dated September 26, 2023, titled ""Press Release - USFDA Delegation visits the Company s Unit I at Choutuppal, Telangana, India"".","26-Sep-2023 15:11:45","2023-09-26 15:11:45","26-Sep-2023 15:11:48","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_26092023151145_Press_Release_26092023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated September 26, 2023, titled ""Press Release - USFDA Delegation visits the Company s Unit I at Choutuppal, Telangana, India"".","26-Sep-2023 15:00:10","2023-09-26 15:00:10","26-Sep-2023 15:00:21","00:00:11","https://nsearchives.nseindia.com/corporate/DIVISLAB_26092023150011_Press_Release.pdf"
"DIVISLAB","Divi's Laboratories Limited","Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","DIVI'S LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","28-Aug-2023 18:14:46","2023-08-28 18:14:46","28-Aug-2023 18:14:51","00:00:05","https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_28082023181446_CIM_9985_923786_28082023061446_WEB.xml"
"DIVISLAB","Divi's Laboratories Limited","Resignation","Divi's Laboratories Limited has informed the Exchange regarding Resignation of Mr Madhusudana Rao Divi  as Whole-time Director of the company w.e.f. August 28, 2023.","28-Aug-2023 18:06:03","2023-08-28 18:06:03","28-Aug-2023 18:06:08","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_28082023180603_Intimation_Reg30_DirectorRetirement.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 28, 2023. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.","28-Aug-2023 17:02:55","2023-08-28 17:02:55","28-Aug-2023 17:02:59","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_28082023170255_Outcome_33rdAGM_DIVISLAB.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Transcript","19-Aug-2023 10:50:14","2023-08-19 10:50:14","19-Aug-2023 10:50:24","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_19082023105014_Earnings_Call_Transcript_Q1FY24_14082023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Link of Recording","14-Aug-2023 16:33:49","2023-08-14 16:33:49","14-Aug-2023 16:33:59","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_14082023163349_Concall_Recording_Q1FY24.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Compliance of Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","14-Aug-2023 16:31:26","2023-08-14 16:31:26","14-Aug-2023 16:31:37","00:00:11","https://nsearchives.nseindia.com/corporate/DIVISLAB_14082023163126_Intimation_regulation_30_5_.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on August 14, 2023.","14-Aug-2023 12:58:22","2023-08-14 12:58:22","14-Aug-2023 12:58:32","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_14082023125822_Outcome_BoardMeeting_Q1FY24results.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2023.","14-Aug-2023 12:55:25","2023-08-14 12:55:25","14-Aug-2023 12:55:35","00:00:10","https://nsearchives.nseindia.com/corporate/Outcome_BoardMeeting_Q1FY24results_14082023125525.pdf"
"DIVISLAB","Divi's Laboratories Limited","Board Meeting Intimation","DIVI'S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 .","07-Aug-2023 11:11:33","2023-08-07 11:11:33","07-Aug-2023 11:11:45","00:00:12","https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_07082023111133_PRIOR_INTIMATION_9014_909713_07082023111133_WEB.xml"
"DIVISLAB","Divi's Laboratories Limited","Notice Of Shareholders Meetings-XBRL","DIVI'S LABORATORIES LIMITED has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 28-Aug-2023","07-Aug-2023 10:47:21","2023-08-07 10:47:21","07-Aug-2023 10:47:31","00:00:10","https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_07082023104721_NOTICE_OF_SHAREHOLDERS_MEETINGS_909702_07082023104721_WEB.xml"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","04-Aug-2023 12:47:13","2023-08-04 12:47:13","04-Aug-2023 12:47:38","00:00:25","https://nsearchives.nseindia.com/corporate/DIVISLAB_04082023124713_Intimation_post_despatch_PaperAd.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the Financial Year ended March 31, 2023'.","03-Aug-2023 10:04:30","2023-08-03 10:04:30","03-Aug-2023 10:04:43","00:00:13","https://nsearchives.nseindia.com/corporate/DIVISLAB_03082023100430_Submission_BRSR2022_23_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 28, 2023","02-Aug-2023 17:08:15","2023-08-02 17:08:15","02-Aug-2023 17:08:28","00:00:13","https://nsearchives.nseindia.com/corporate/DIVISLAB_02082023170815_Submission_Annual_Report2022_23_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Loss of Share Certificates","Divi's Laboratories Limited has informed the Exchange about Loss of Share Certificates","28-Jul-2023 13:02:54","2023-07-28 13:02:54","28-Jul-2023 13:03:02","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_28072023130254_Intimation_Loss_of_Share_Certificate.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - Notice informing 33rd Annual General Meeting of the Company to be held on August 28, 2023 through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), Record date for dividend and other information","28-Jul-2023 12:59:49","2023-07-28 12:59:49","28-Jul-2023 12:59:56","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_28072023125949_Intimation_Newspaperclipping_AGM.pdf"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","08-Jul-2023 16:34:15","2023-07-08 16:34:15","08-Jul-2023 16:34:23","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_08072023163415_Reg74_5_Divis30062023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Communication to Shareholders - Information regarding deduction of Income tax at source from payment of Dividend for the financial year 2022-23'.","05-Jul-2023 09:02:05","2023-07-05 09:02:05","05-Jul-2023 09:02:12","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_05072023090205_Submission_DividendTDS_communcation.pdf"
"DIVISLAB","Divi's Laboratories Limited","Record Date","Divi's Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend  is 11-Aug-2023.","03-Jul-2023 12:49:45","2023-07-03 12:49:45","03-Jul-2023 12:49:53","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_03072023124945_Intimation_of_33rdAGM_date_and_Record_date.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Intimation of date of 33rd Annual General Meeting and Record Date for dividend'.","03-Jul-2023 12:44:26","2023-07-03 12:44:26","03-Jul-2023 12:44:33","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_03072023124426_Intimation_of_33rdAGM_date_and_Record_date.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","28-Jun-2023 16:08:24","2023-06-28 16:08:24","28-Jun-2023 16:08:28","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_28062023160824_Intimation_TradingWindowClosure_Q1Fy24.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Transcript","25-May-2023 16:16:22","2023-05-25 16:16:22","25-May-2023 16:16:32","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_25052023161622_Transcript_EarningsCall_Q4FY23_20052023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Annual Secretarial Compliance Report","Annual Secretarial Compliance Report for the year ended March 31, 2023","23-May-2023 10:07:37","2023-05-23 10:07:37","23-May-2023 10:07:42","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_23052023100737_Reg24A_AnnualSecretarialCompliancecertificate31032023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","22-May-2023 14:50:39","2023-05-22 14:50:39","22-May-2023 14:50:50","00:00:11","https://nsearchives.nseindia.com/corporate/DIVISLAB_22052023145039_Submission_of_newspaper_publication_Q4FY23_results.pdf"
"DIVISLAB","Divi's Laboratories Limited","Related Party Transactions","Divi's Laboratories Limited has informed the Exchange about related Party Transactions","20-May-2023 18:01:26","2023-05-20 18:01:26","20-May-2023 18:01:28","00:00:02","https://nsearchives.nseindia.com/corporate/DIVISLAB_20052023180126_RPT_Statement_31032023_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Link of Recording","20-May-2023 18:00:03","2023-05-20 18:00:03","20-May-2023 18:00:15","00:00:12","https://nsearchives.nseindia.com/corporate/DIVISLAB_20052023180003_EarningsCall_AudioLink_Q4_FY23.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting-XBRL","Divi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on 20-May-2023 for Dividend","20-May-2023 13:39:06","2023-05-20 13:39:06","20-May-2023 13:39:15","00:00:09","https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_20052023133906_OUTCOME_847802_20052023013906_WEB.xml"
"DIVISLAB","Divi's Laboratories Limited","Dividend Updates","Divi's Laboratories Limited has informed the Exchange about Dividend Updates","20-May-2023 13:37:43","2023-05-20 13:37:43","20-May-2023 13:37:46","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_20052023133743_Outcome_Q4FY23_DivisLab_20052023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated May 20, 2023, titled ""Press Release on the Audited Financial Results of the Company for the quarter and year ended March 31, 2023"".","20-May-2023 13:35:04","2023-05-20 13:35:04","20-May-2023 13:35:08","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_20052023133504_Submssion_PressRelease_Q4FY23_20052023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023.","20-May-2023 13:27:16","2023-05-20 13:27:16","20-May-2023 13:27:22","00:00:06","https://nsearchives.nseindia.com/corporate/Outcome_Q4FY23_DivisLab_20052023_20052023132716.pdf"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 20, 2023, recommended Final Dividend of 30 per equity share.","20-May-2023 13:23:10","2023-05-20 13:23:10","20-May-2023 13:23:15","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_20052023132310_Outcome_Q4FY23_DivisLab_20052023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Murali K. Divi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.","19-May-2023 16:33:59","2023-05-19 16:33:59","19-May-2023 16:34:05","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_19052023163359_Reg.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Schedule of meet","15-May-2023 12:27:09","2023-05-15 12:27:09","15-May-2023 12:27:13","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_15052023122709_Q4FY23Concall_schedule_intimation.pdf"
"DIVISLAB","Divi's Laboratories Limited","Board Meeting Intimation","DIVI'S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 20-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend.","12-May-2023 10:47:08","2023-05-12 10:47:08","12-May-2023 10:47:10","00:00:02","https://nsearchives.nseindia.com/corporate/xbrl/DIVISLAB_12052023104708_PRIOR_INTIMATION_4149_841090_12052023104707_WEB.xml"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Clarification to query on  Increase in Volume '.","13-Apr-2023 14:56:46","2023-04-13 14:56:46","13-Apr-2023 14:56:58","00:00:12","https://nsearchives.nseindia.com/corporate/DIVISLAB_13042023145646_Reply_to_BSE13042023DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","07-Apr-2023 16:38:25","2023-04-07 16:38:25","07-Apr-2023 16:38:27","00:00:02","https://nsearchives.nseindia.com/corporate/DIVISLAB_07042023163825_Reg74_5_Divis31032023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","31-Mar-2023 10:16:57","2023-03-31 10:16:57","31-Mar-2023 10:17:02","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_31032023101657_Intimation_trading_window_closure_31032023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Schedule of meet","11-Mar-2023 15:34:08","2023-03-11 15:34:08","11-Mar-2023 15:34:53","00:00:45","https://nsearchives.nseindia.com/corporate/DIVISLAB_11032023153408_Intimation_Schedule_of_InvestorsMeeting_on_13032023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Transcript","08-Feb-2023 14:54:28","2023-02-08 14:54:28","08-Feb-2023 14:54:33","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_08022023145428_Transcript_Earnings_call_Q3Fy23_Divislab03022022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","04-Feb-2023 15:43:53","2023-02-04 15:43:53","04-Feb-2023 15:43:55","00:00:02","https://nsearchives.nseindia.com/corporate/DIVISLAB_04022023154353_Newspaper_publication_Q3FY23results_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Link of Recording","03-Feb-2023 16:32:37","2023-02-03 16:32:37","03-Feb-2023 16:32:42","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_03022023163237_Reg30_Q3FY23Earningscall_Audio_03022023.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022.","03-Feb-2023 12:50:51","2023-02-03 12:50:51","03-Feb-2023 12:50:55","00:00:04","https://nsearchives.nseindia.com/corporate/Outcome_Q3FY23BoardMeeting_03022023_03022023125051.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Schedule of earnings call for Q3FY23 results","25-Jan-2023 09:17:08","2023-01-25 09:17:08","25-Jan-2023 09:17:15","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_25012023091708_Intimation_ConcallScheduleQ3FY23Results_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","07-Jan-2023 11:27:02","2023-01-07 11:27:02","07-Jan-2023 11:27:06","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_07012023112702_Reg74_Divis31122022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","24-Dec-2022 14:21:10","2022-12-24 14:21:10","24-Dec-2022 14:21:15","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_24122022142110_TradingWindowclosurefrom_01012023_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding Notice given to shareholders in respect of transfer of equity shares to IEPF Account.","24-Dec-2022 11:34:32","2022-12-24 11:34:32","24-Dec-2022 11:34:35","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_24122022113432_IEPF_NewpaperPublication_24122022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Transcript of Analysts/Institutional Investor Meet/Con. Call","Divi's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call ","14-Nov-2022 16:39:39","2022-11-14 16:39:39","14-Nov-2022 16:39:44","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_14112022163939_Concall_Transcript_Q2FY23.pdf"
"DIVISLAB","Divi's Laboratories Limited","Related Party Transaction","Divi's Laboratories Limited has informed the Exchange about related party transaction for the period ended September 2022","14-Nov-2022 16:13:30","2022-11-14 16:13:30","14-Nov-2022 16:13:35","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_14112022161330_RPT_30092022_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Newspaper Advertisements","Divi's Laboratories Limited has informed the Exchange about Newspaper Advertisements - Extracts of unaudited financial results for the quarter and half year ended September 30, 2022 ","08-Nov-2022 16:10:09","2022-11-08 16:10:09","08-Nov-2022 16:10:17","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_08112022161009_Newspaper_publication_Q2FY23results_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Reply to Clarification Sought- Financial Results","Dear Sir/Madam,As soon as we have uploaded quick results on 12.08.2022, we realized the file was not readable and spoke to NSE officials. We were advised to file the machine readable document of the submission under miscelleneous filings. We have filed machine readable outcome of Board Meeting vide Application No. 2022082098491 on 12-Aug-2022 at 13:03:43 hrs. We have seen the clarification raised just now and were unaware of the clarification requested till today. ","07-Nov-2022 17:34:09","2022-11-07 17:34:09","07-Nov-2022 17:34:13","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_07112022173409_Acknowledgement_file_12Aug2022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Recording of Analysts/Institutional Investor Meet/Con. Call","Divi's Laboratories Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call","07-Nov-2022 16:40:24","2022-11-07 16:40:24","07-Nov-2022 16:40:26","00:00:02","https://nsearchives.nseindia.com/corporate/DIVISLAB_07112022164024_Intimation_EarningsCall_AudioLink_Divis07112022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited  has informed the Exchange about Board Meeting held on 07-Nov-2022 to consider financial statements for the period ended September 2022","07-Nov-2022 12:52:21","2022-11-07 12:52:21","07-Nov-2022 12:52:32","00:00:11","https://nsearchives.nseindia.com/corporate/DIVISLAB_07112022125221_Outcome_Board_MeetingQ2Fy23_DivisLab07112022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Divi's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","28-Oct-2022 16:50:30","2022-10-28 16:50:30","28-Oct-2022 16:50:37","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_28102022165030_Concall_intimationQ3FY23.pdf"
"DIVISLAB","Divi's Laboratories Limited","General updates","Divi's Laboratories Limited has informed the Exchange about Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022","12-Oct-2022 10:43:09","2022-10-12 10:43:09","12-Oct-2022 10:43:16","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_12102022104309_Certificate_74_5_DivisLabs30092022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Closure of trading window","Divi's Laboratories Limited has informed the Exchange about Closure of trading window","29-Sep-2022 17:09:09","2022-09-29 17:09:09","29-Sep-2022 17:09:14","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_29092022170909_Trading_Window_Closure01102022_DivisLabs.pdf"
"DIVISLAB","Divi's Laboratories Limited","Annual General Meeting","Divi's Laboratories Limited has informed the Exchange about Voting results,  Scrutinizer report and  Proceedings of Annual General Meeting held on 22-Aug-2022","22-Aug-2022 16:49:20","2022-08-22 16:49:20","22-Aug-2022 16:49:24","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_22082022164920_Outcome_of_AGM_Proceedings_VotingResults_ScrutinizersReport_DivisLab22082022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Transcript of Analysts/Institutional Investor Meet/Con. Call","Divi's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call ","17-Aug-2022 13:59:21","2022-08-17 13:59:21","17-Aug-2022 13:59:24","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_17082022135921_Transcript_EarningsCall_Q1FY23_12082022Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Newspaper Advertisements","Divi's Laboratories Limited has informed the Exchange about Newspaper Advertisements","13-Aug-2022 15:02:15","2022-08-13 15:02:15","13-Aug-2022 15:02:19","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_13082022150215_Newspaper_Ad_Q1FY23results.pdf"
"DIVISLAB","Divi's Laboratories Limited","Recording of Analysts/Institutional Investor Meet/Con. Call","Divi's Laboratories Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call","12-Aug-2022 16:57:00","2022-08-12 16:57:00","12-Aug-2022 16:57:03","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_12082022165700_Audio_Earnings_call_Q1FY22_12082022.pdf"
"DIVISLAB","Divi's Laboratories Limited","General updates","Divi's Laboratories Limited has informed the Exchange about Outcome of Board Meeting held on 12.08.2022.","12-Aug-2022 13:03:45","2022-08-12 13:03:45","12-Aug-2022 13:03:51","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_12082022130345_Outcome_BoardMeeting_Q1FY23_12082022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited  has informed the Exchange about Board Meeting held on 12-Aug-2022 to consider financial statements for the period ended June 2022","12-Aug-2022 12:25:51","2022-08-12 12:25:51","12-Aug-2022 12:25:54","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_12082022122551_Outcome_BoardMeeting_Q1FY23_12082022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Divi's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","29-Jul-2022 16:35:21","2022-07-29 16:35:21","29-Jul-2022 16:35:28","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_29072022163521_Schedule_EarningsCall_Q1Fy23_Divislab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Newspaper Advertisements","Divi's Laboratories Limited has informed the Exchange about Newspaper Advertisement regarding Notice of the 32nd Annual General Meeting, e-voting and other information to the shareholders.","26-Jul-2022 12:02:18","2022-07-26 12:02:18","26-Jul-2022 12:02:22","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_26072022120218_Newspaper_Publication_AGMnoticeDispatch_Evoting_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Annual General Meeting","Divi's Laboratories Limited has informed the Exchange about Notice of Annual General Meeting to be held on 22-Aug-2022","25-Jul-2022 10:47:24","2022-07-25 10:47:24","25-Jul-2022 10:47:27","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_25072022104724_AnnualReport_AGMnotice_2021_22DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Newspaper Advertisements","Divi's Laboratories Limited has informed the Exchange about Newspaper Advertisements - Notice informing 32nd Annual General Meeting of the Company to be held on August 22, 2022 through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).","20-Jul-2022 12:14:30","2022-07-20 12:14:30","20-Jul-2022 12:14:32","00:00:02","https://nsearchives.nseindia.com/corporate/DIVISLAB_20072022121430_Newspaper_Publication_Intimation_32ndAGM_through_VC_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","General updates","Divi's Laboratories Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2022","11-Jul-2022 12:56:00","2022-07-11 12:56:00","11-Jul-2022 12:56:11","00:00:11","https://nsearchives.nseindia.com/corporate/DIVISLAB_11072022125600_Certificate_reg745_30062022_Divislab.pdf"
"DIVISLAB","Divi's Laboratories Limited","General updates","Divi's Laboratories Limited has informed the Exchange about Communication to Shareholders - Information regarding deduction of Income tax at source on dividend","05-Jul-2022 14:38:57","2022-07-05 14:38:57","05-Jul-2022 14:39:00","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_05072022143857_Intimation_TDScommunication_Divislab.pdf"
"DIVISLAB","Divi's Laboratories Limited","General updates","Divi's Laboratories Limited has informed the Exchange about Intimation of date of Annual General Meeting and Record Date","04-Jul-2022 16:25:03","2022-07-04 16:25:03","04-Jul-2022 16:25:06","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_04072022162503_Intimation_AGMdate_RecordDate_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Record Date","Divi's Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend  is 12-Aug-2022.","04-Jul-2022 16:23:27","2022-07-04 16:23:27","04-Jul-2022 16:23:31","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_04072022162327_Intimation_AGMdate_RecordDate_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Closure of trading window","Divi's Laboratories Limited has informed the Exchange about Closure of trading window","30-Jun-2022 10:15:51","2022-06-30 10:15:51","30-Jun-2022 10:15:55","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_30062022101551_Intimation_Trading_Window_Closure_30062022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Related Party Transaction","Divi's Laboratories Limited has informed the Exchange about related party transaction for the period ended March 2022","01-Jun-2022 16:50:45","2022-06-01 16:50:45","01-Jun-2022 16:50:48","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_01062022165045_Halfyearly_RPT_statement31032022_to_StockExchanges.pdf"
"DIVISLAB","Divi's Laboratories Limited","Newspaper Advertisements","Divi's Laboratories Limited has informed the Exchange about Newspaper Advertisements - Intimation of Notice given to shareholders in respect of transfer of equity shares to IEPF Account ","31-May-2022 14:49:42","2022-05-31 14:49:42","31-May-2022 14:49:52","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_31052022144942_IEPFNotice_to_Shareholders_31052022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Transcript of Analysts/Institutional Investor Meet/Con. Call","Divi's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call ","26-May-2022 12:24:18","2022-05-26 12:24:18","26-May-2022 12:24:26","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_26052022122000_Earnings_Call_Transcript_Q4FY22_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Recording of Analysts/Institutional Investor Meet/Con. Call","Divi's Laboratories Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call","23-May-2022 17:32:23","2022-05-23 17:32:23","23-May-2022 17:32:25","00:00:02","https://nsearchives.nseindia.com/corporate/DIVISLAB_23052022173219_EarningsCallAudio_Q4Fy22_DivisLab23052022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited  has informed the Exchange about Board Meeting held on 23-May-2022 to consider financial statements for the period ended March 2022 and Dividend","23-May-2022 12:29:41","2022-05-23 12:29:41","23-May-2022 12:29:49","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_23052022122940_Outcome_Q4FY22_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on 23-May-2022, declared Dividend of Rs. 30 per equity share.","23-May-2022 12:29:38","2022-05-23 12:29:38","23-May-2022 12:29:47","00:00:09","https://nsearchives.nseindia.com/corporate/DIVISLAB_23052022122931_Outcome_Q4FY22_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.","23-May-2022 12:21:33","2022-05-23 12:21:33","23-May-2022 12:23:02","00:01:29","https://nsearchives.nseindia.com/corporate/Outcome_Q4FY22_Divis_23052022122133.pdf"
"DIVISLAB","Divi's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Divi's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call -  Schedule of earnings conference call Q4 and full year FY22 ","16-May-2022 16:43:10","2022-05-16 16:43:10","16-May-2022 16:43:17","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_16052022164310_Schedule_of_Earnings_call_Q4FY22.pdf"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Promoter/Promoter Group of Divi's Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022","09-Apr-2022 11:53:33","2022-04-09 11:53:33","09-Apr-2022 11:53:35","00:00:02","https://nsearchives.nseindia.com/corporate/AN_O09042022115333.xlsx"
"DIVISLAB","Divi's Laboratories Limited","General updates","Divi's Laboratories Limited has informed the Exchange about Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2022","08-Apr-2022 16:02:53","2022-04-08 16:02:53","08-Apr-2022 16:03:25","00:00:32","https://nsearchives.nseindia.com/corporate/DIVISLAB_08042022160253_Reg74_5_DivisLab31032022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Promoter/Promoter Group of Divi's Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022","04-Apr-2022 12:24:19","2022-04-04 12:24:19","04-Apr-2022 12:24:24","00:00:05","https://nsearchives.nseindia.com/corporate/AN_O04042022122419.xlsx"
"DIVISLAB","Divi's Laboratories Limited","Closure of trading window","Divi's Laboratories Limited has informed the Exchange about Closure of trading window that pursuant to the Company's Code of Conduct for Prevention of lnsider Trading (the Code),  Trading Window for dealing in securities of the Company will remain closed for all Designated Persons and their Immediate Relatives, as well as Insiders covered under the Code, from April 01, 2022 till 48 hours after the declaration of Audited Financial Results for the fourth quarter and year ending March 31, 2022.The date of Board meeting for declaration of the financial results of the Company for the fourth quarter and year ending March 31, 2022 will be intimated in due course.","31-Mar-2022 12:04:19","2022-03-31 12:04:19","31-Mar-2022 12:04:31","00:00:12","https://nsearchives.nseindia.com/corporate/DIVISLAB_31032022120419_Trading_Window_Closure_01042022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot","Divi's Laboratories Limited has informed the Exchange about Voting results and  Scrutinizer report of Postal Ballot, conducted vide Notice of Postal Ballot dated February 11, 2022.","28-Mar-2022 14:14:57","2022-03-28 14:14:57","28-Mar-2022 14:15:01","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_28032022141454_Voting_results_PostalBallot_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","General updates","Divi's Laboratories Limited has informed the Exchange about Change of name of the Registrar and Share Transfer Agent of the Company from ￢ﾀﾜKFin Technologies Private Limited￢ﾀﾝ to ￢ﾀﾜKFin Technologies Limited￢ﾀﾝ","22-Mar-2022 15:09:16","2022-03-22 15:09:16","22-Mar-2022 15:09:23","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_22032022150914_Intimation_RTAnamechange_22032022_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Newspaper Advertisements","Divi's Laboratories Limited has informed the Exchange about Newspaper Advertisements","26-Feb-2022 11:40:10","2022-02-26 11:40:10","26-Feb-2022 11:40:20","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_26022022114010_Newspaper_dispatch_PB_DivisLabs26022022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Newspaper Advertisements","Divi's Laboratories Limited has informed the Exchange about Newspaper Advertisements","25-Feb-2022 12:21:14","2022-02-25 12:21:14","25-Feb-2022 12:21:35","00:00:21","https://nsearchives.nseindia.com/corporate/DIVISLAB_25022022122114_Intimation_NewspaperPublication.pdf"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot","Divi's Laboratories Limited has informed the Exchange about Notice of Postal Ballot","24-Feb-2022 19:48:46","2022-02-24 19:48:46","24-Feb-2022 19:51:54","00:03:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_24022022194846_SEIntimationPBNotice_DivisLabs11022022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot","Divi's Laboratories Limited has informed the Exchange about Notice of Postal Ballot","24-Feb-2022 11:55:25","2022-02-24 11:55:25","24-Feb-2022 11:55:31","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_24022022115525_SEIntimationPBNotice_DivisLabs11022022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on February 11, 2022.","11-Feb-2022 12:11:03","2022-02-11 12:11:03","11-Feb-2022 12:11:11","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_11022022121102_BoardMeetingoutcome_DivisLabs11022022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2021.","11-Feb-2022 11:59:27","2022-02-11 11:59:27","11-Feb-2022 12:01:01","00:01:34","https://nsearchives.nseindia.com/corporate/ResultsQ3FY22_DivisLabs_11022022115927.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Revised schedule of earnings conference call Q3 FY22","03-Feb-2022 15:10:14","2022-02-03 15:10:14","03-Feb-2022 15:10:20","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_03022022151014_Revised_EarningsCallSchedule_Q3FY22.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Schedule of Earnings Conference Call Q3 FY22","28-Jan-2022 14:35:56","2022-01-28 14:35:56","28-Jan-2022 14:36:12","00:00:16","https://nsearchives.nseindia.com/corporate/DIVISLAB_28012022143556_Intimation_Earningscall_Q3FY22_DivisLab04022022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","07-Jan-2022 09:44:54","2022-01-07 09:44:54","07-Jan-2022 09:45:00","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_07012022094454_Certificate74_5_DIVISLAB_31122021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Loss of Share Certificates","Divi's Laboratories Limited has informed the Exchange about Loss of Share Certificates","06-Jan-2022 16:38:36","2022-01-06 16:38:36","06-Jan-2022 16:38:42","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_06012022163836_Intimation_Loss_of_ShareCertificate06012022.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","31-Dec-2021 10:21:22","2021-12-31 10:21:22","31-Dec-2021 10:21:31","00:00:09","https://nsearchives.nseindia.com/corporate/DIVISLAB_31122021102122_Intimation_TradingWindowClosure_31122021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on November 06, 2021.","06-Nov-2021 11:59:34","2021-11-06 11:59:34","06-Nov-2021 11:59:39","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_06112021115934_Q2FY22Results_DivisLab06112021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021.","06-Nov-2021 11:48:08","2021-11-06 11:48:08","06-Nov-2021 11:50:02","00:01:54","https://nsearchives.nseindia.com/corporate/Q2FY22Results_DivisLab06112021_06112021114808.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Schedule of Earnings Conference Call Q2 FY22","02-Nov-2021 08:45:13","2021-11-02 08:45:13","02-Nov-2021 08:45:17","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_02112021084513_Intimation_EarningscallSchedule_DivisLab06112021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","07-Oct-2021 16:42:18","2021-10-07 16:42:18","07-Oct-2021 16:42:24","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_07102021164218_CertificateReg74_5_DivisLabs30092021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","30-Sep-2021 10:24:37","2021-09-30 10:24:37","30-Sep-2021 10:24:45","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_30092021102437_Intimation_TradingWindowClosure_Q2DivisLabs.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 30, 2021. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.","30-Aug-2021 17:12:03","2021-08-30 17:12:03","30-Aug-2021 17:12:10","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_30082021171203_AGMproceedings_VotingResults_ScrutinizersReport_DivisLabs30082021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Chairman s Speech and Managing Director s Speech delivered at the 31st Annual General Meeting of the Company'.","30-Aug-2021 12:15:06","2021-08-30 12:15:06","30-Aug-2021 12:15:12","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_30082021121506_AGMSpeeches2021DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Outcome of Board Meeting   Submission of Unaudited financial results for the quarter ended June 30, 2021","07-Aug-2021 12:08:50","2021-08-07 12:08:50","07-Aug-2021 12:08:54","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_07082021120849_Outcome_boardmeeting_Q1_07082021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021.","07-Aug-2021 12:06:44","2021-08-07 12:06:44","07-Aug-2021 12:08:02","00:01:18","https://nsearchives.nseindia.com/corporate/Outcome_boardmeeting_Q1_07082021_07082021120644.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","04-Aug-2021 15:04:23","2021-08-04 15:04:23","04-Aug-2021 15:04:26","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_04082021150423_Newspaper_Publication_AGM_Notice_Evoting_and_other_information_04082021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates","03-Aug-2021 10:53:03","2021-08-03 10:53:03","03-Aug-2021 10:53:11","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_03082021105303_Intimation_EarningsCall_Q1FY22_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 30, 2021","02-Aug-2021 13:19:49","2021-08-02 13:19:49","02-Aug-2021 13:19:53","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_02082021131949_Annual_Report_2020_21_DivisLabs.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","21-Jul-2021 14:15:40","2021-07-21 14:15:40","21-Jul-2021 14:15:51","00:00:11","https://nsearchives.nseindia.com/corporate/DIVISLAB_21072021141540_Paper_Adv_21072021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Dividend Updates","Divi's Laboratories Limited has informed the Exchange about Dividend Updates","20-Jul-2021 09:31:44","2021-07-20 09:31:44","20-Jul-2021 09:31:49","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_20072021093144_Information_regarding_deduction_of_tax_on_dividend.pdf"
"DIVISLAB","Divi's Laboratories Limited","Book Closure","Divi's Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 20-Aug-2021 to 22-Aug-2021 for the purpose of Dividend.","19-Jul-2021 16:38:42","2021-07-19 16:38:42","19-Jul-2021 16:38:45","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_19072021163842_Intimation_AGMdateBookClosure_19072021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Intimation of date of Annual General Meeting and Book Closure'.","19-Jul-2021 16:32:59","2021-07-19 16:32:59","19-Jul-2021 16:33:03","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_19072021163259_Intimation_AGMdateBookClosure_19072021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","09-Jul-2021 16:59:53","2021-07-09 16:59:53","09-Jul-2021 16:59:57","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_09072021165953_Reg74_5__DivisLab_30062021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","30-Jun-2021 10:16:30","2021-06-30 10:16:30","30-Jun-2021 10:16:40","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_30062021101630_Intimation_TradingWindowClosure_DivisLab30062021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Related Party Transactions","Divi's Laboratories Limited has informed the Exchange about related Party Transactions","01-Jun-2021 11:35:26","2021-06-01 11:35:26","01-Jun-2021 11:35:31","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_01062021113526_Reg23_9__31032021_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on May 29, 2021.","31-May-2021 20:58:18","2021-05-31 20:58:18","31-May-2021 20:58:28","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_31052021205817_Divi_outcome.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021.","29-May-2021 20:17:10","2021-05-29 20:17:10","29-May-2021 20:19:01","00:01:51","https://nsearchives.nseindia.com/corporate/Outcome_BM_Financial_ResultsQ4FY21_DivisLabs_29052021201710.pdf"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2021, recommended Final Dividend of 20 per equity share.","29-May-2021 20:10:48","2021-05-29 20:10:48","29-May-2021 20:10:54","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_29052021201047_Outcome_BM_Financial_ResultsQ4FY21_DivisLabs.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Intimation about manufacturing of Molnupiravir API'.","26-May-2021 12:54:13","2021-05-26 12:54:13","26-May-2021 12:54:25","00:00:12","https://nsearchives.nseindia.com/corporate/DIVISLAB_26052021125413_SEIntimation26052021_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates","22-May-2021 11:19:52","2021-05-22 11:19:52","22-May-2021 11:19:57","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_22052021111952_SE_Intimation_concallScheduleQ4FY21_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under SEBI Takeover Regulations","ￂﾠPromoter/Member of the Promoter Group of the Company has informed the Exchange regarding disclosure under Regulation 30 of SEBI SAST Regulations, 2011 as on March 31, 2021.","10-May-2021 18:37:29","2021-05-10 18:37:29","10-May-2021 18:37:39","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_10052021183729_divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","10-May-2021 14:45:59","2021-05-10 14:45:59","10-May-2021 14:46:12","00:00:13","https://nsearchives.nseindia.com/corporate/DIVISLAB_10052021144559_Reg30_IEPF_Paper_publication_10052021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under SEBI Takeover Regulations","ￂﾠPromoter/Member of the Promoter Group of the Company has informed the Exchange regarding disclosure under Regulation 30 and Regulation 31(4) of SEBI SAST Regulations 2011ￂﾠas at March 31, 2021.","22-Apr-2021 11:03:14","2021-04-22 11:03:14","22-Apr-2021 11:03:21","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_22042021110313_Divi30_22042021095724.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Promoter/Member of the Promoter Group of the Company has informed the Exchange regarding disclosure under Regulation 30 and Regulation 31(4) of SEBI SAST Regulations 2011 as on March 31, 2021","15-Apr-2021 15:19:30","2021-04-15 15:19:30","15-Apr-2021 15:19:34","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_15042021151929_divi_15042021142850.zip"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","06-Apr-2021 15:02:37","2021-04-06 15:02:37","06-Apr-2021 15:02:40","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_06042021150237_Reg_74_5_DivisLab_31032021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","31-Mar-2021 08:39:40","2021-03-31 08:39:40","31-Mar-2021 08:39:50","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_31032021083940_Intimation_TradingWindowClosure_31032021_Divislab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Loss of Share Certificates","Divi's Laboratories Limited has informed the Exchange about Loss of Share Certificates","24-Mar-2021 16:40:27","2021-03-24 16:40:27","24-Mar-2021 16:40:32","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_24032021164027_loss_of_certificate_Rajeswari_C_Alur_24032021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on February 06, 2021.","06-Feb-2021 12:17:40","2021-02-06 12:17:40","06-Feb-2021 12:17:46","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_06022021121740_Outcome_Q3Results_DivisLabs_06022021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.","06-Feb-2021 12:15:34","2021-02-06 12:15:34","06-Feb-2021 12:17:01","00:01:27","https://nsearchives.nseindia.com/corporate/Outcome_Q3Results_DivisLabs_06022021_06022021121534.zip"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates","29-Jan-2021 14:12:19","2021-01-29 14:12:19","29-Jan-2021 14:12:26","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_29012021141219_Intimation_EarningsConferenceCallQ3_06022021_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","07-Jan-2021 10:18:44","2021-01-07 10:18:44","07-Jan-2021 10:18:48","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_07012021101844_Reg74_5_31122020_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","31-Dec-2020 11:31:23","2020-12-31 11:31:23","31-Dec-2020 11:31:28","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_31122020113123_Intimation_TradingWIndowClosure_31122020_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Commencement of construction of Divi's Laboratories Unit-III Facility near Kakinada'.","01-Dec-2020 10:52:26","2020-12-01 10:52:26","01-Dec-2020 10:52:29","00:00:03","https://nsearchives.nseindia.com/corporate/DIVISLAB_01122020105226_Intimation_Unit3_DivisLab01122020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Revised  Disclosure under Regulation 7(2) of SEBI (Prohibition ofInsider Trading) Regulations, 2015'.","23-Nov-2020 16:43:56","2020-11-23 16:43:56","23-Nov-2020 16:44:00","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_23112020164356_Revised_PIT_Disclosure.pdf"
"DIVISLAB","Divi's Laboratories Limited","Related Party Transactions","Divi's Laboratories Limited has informed the Exchange about related Party Transactions","23-Nov-2020 12:29:58","2020-11-23 12:29:58","23-Nov-2020 12:30:09","00:00:11","https://nsearchives.nseindia.com/corporate/DIVISLAB_23112020122958_RTP30092020DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Loss of Share Certificates","Divi's Laboratories Limited has informed the Exchange about Loss of Share Certificates","17-Nov-2020 10:59:33","2020-11-17 10:59:33","17-Nov-2020 10:59:37","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_17112020105933_Reg39_3_LossofShareCertificate_17112020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on November 07, 2020.","07-Nov-2020 12:44:06","2020-11-07 12:44:06","07-Nov-2020 12:44:13","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_07112020124406_Q2_results_DivisLabs.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2020.","07-Nov-2020 12:35:09","2020-11-07 12:35:09","07-Nov-2020 12:37:01","00:01:52","https://nsearchives.nseindia.com/corporate/Q2_results_DivisLabs_07112020123509.zip"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates","30-Oct-2020 11:04:17","2020-10-30 11:04:17","30-Oct-2020 11:04:25","00:00:08","https://nsearchives.nseindia.com/corporate/DIVISLAB_30102020110417_Reg30_Intimation_EarningsCall_DivisLabs_30102020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","23-Oct-2020 14:06:37","2020-10-23 14:06:37","23-Oct-2020 14:06:41","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_23102020140637_Reg30_Intimation_DivisLab_23102020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Submission of Certificate under Regulation 74(5) of SEBI (Depositories andParticipants) Regulations, 2018 for the quarter ended 30 September, 2020'.","13-Oct-2020 10:54:20","2020-10-13 10:54:20","13-Oct-2020 10:54:24","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_13102020105420_Reg74_5_30092020_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","30-Sep-2020 09:54:32","2020-09-30 09:54:32","30-Sep-2020 09:54:36","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_30092020095432_Intimation_TradingWindowClosure_DivisLabs30092020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'News clarification '.","16-Sep-2020 09:52:01","2020-09-16 09:52:01","16-Sep-2020 09:52:11","00:00:10","https://nsearchives.nseindia.com/corporate/DIVISLAB_16092020095201_NewsClarification_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 14, 2020. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.","14-Sep-2020 18:55:48","2020-09-14 18:55:48","14-Sep-2020 18:55:52","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_14092020185548_AGMproceedings_Voting_ScrutinizersReport_DivisLabs14092020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Chairman s Speech and Managing Director s Speech delivered at the 30th Annual General Meeting of the Company'.","14-Sep-2020 12:30:41","2020-09-14 12:30:41","14-Sep-2020 12:30:48","00:00:07","https://nsearchives.nseindia.com/corporate/DIVISLAB_14092020123041_Chairman_MD_Speech_DivisAGM_14092020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","21-Aug-2020 14:48:22","2020-08-21 14:48:22","21-Aug-2020 14:48:27","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_21082020144822_Newspaper_Adv_21082020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 14, 2020","19-Aug-2020 10:57:48","2020-08-19 10:57:48","19-Aug-2020 10:57:54","00:00:06","https://nsearchives.nseindia.com/corporate/DIVISLAB_19082020105748_30th_AnnualReport_201920_DivisLabs.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","18-Aug-2020 12:10:52","2020-08-18 12:10:52","18-Aug-2020 12:10:57","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_18082020121052_Newspaper_advertisement_18082020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Book Closure","Divi's Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 08-Sep-2020 to 14-Sep-2020 for the purpose of Annual General Meeting.","17-Aug-2020 18:02:18","2020-08-17 18:02:18","17-Aug-2020 18:02:22","00:00:04","https://nsearchives.nseindia.com/corporate/DIVISLAB_17082020180218_Intimation_AGMdate_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding '30th Annual General Meeting of the Company to be held on 14 September, 2020 '.","17-Aug-2020 17:56:15","2020-08-17 17:56:15","17-Aug-2020 17:56:20","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_17082020175615_Intimation_AGMdate_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","13-Aug-2020 12:42:47","2020-08-13 12:42:47","13-Aug-2020 12:42:52","00:00:05","https://nsearchives.nseindia.com/corporate/DIVISLAB_13082020124247_Newspaper_Adv_13082020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.","08-Aug-2020 12:37:25","2020-08-08 12:37:25","08-Aug-2020 12:39:01","00:01:36","https://nsearchives.nseindia.com/corporate/Outcome_BoardMeeting_resultsQ108082020Divis_08082020123725.zip"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates - Schedule of Earnings Conference Call Q1 FY21 to be held on 08 August, 2020","05-Aug-2020 15:21:42","2020-08-05 15:21:42","05-Aug-2020 15:22:13","00:00:31","https://nsearchives.nseindia.com/corporate/DIVISLAB_05082020152142_SE_Intimation_earnings_callQ1_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Intimation of Chief Financial Officer going on leave '.","18-Jul-2020 17:34:00","2020-07-18 17:34:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_18072020173438_IntimationStockExchanges18072020Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Submission of Certificate under Regulation 74(5) of SEBI (Depositories andParticipants) Regulations, 2018 for the quarter ended 30 June, 2020'.","15-Jul-2020 09:38:00","2020-07-15 09:38:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_15072020093852_Reg74_5_Divis_3062020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","02-Jul-2020 16:12:00","2020-07-02 16:12:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_02072020161257_Regulation_30_intimation_02072020Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Related Party Transactions","Divi's Laboratories Limited has informed the Exchange about related Party Transactions","01-Jul-2020 16:18:00","2020-07-01 16:18:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_01072020161841_Divis_RPT_31032020_SE.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","30-Jun-2020 10:38:00","2020-06-30 10:38:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30062020103812_Notice_of_Trading_Window_Closure_01072020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Copy of Newspaper Publication","Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication of notice to shareholders of the Company intimating that equity shares in respect of which dividend remain unclaimed for seven consecutive years would be transferred to Investor Education and Protection Fund (IEPF) Authority. This notice was published on 20 June, 2020 in the following newspapers: Financial Express (English Daily), Andhra Prabha (Telugu Daily)","20-Jun-2020 16:08:00","2020-06-20 16:08:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_20062020160847_Newspaper_Publication_Details_of_shares_to_be_transfered_to_IEPF.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.","06-Jun-2020 14:51:39","2020-06-06 14:51:39","-","-","https://nsearchives.nseindia.com/corporate/Results_submission060620Divis_06062020145139.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Divi's Laboratories Limited has informed the Exchange regarding Disclosure under Regulations 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011","30-Apr-2020 13:37:00","2020-04-30 13:37:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30042020133745_DIVIS.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March, 2020'.","17-Apr-2020 11:38:00","2020-04-17 11:38:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_17042020113854_Reg74_5_Divis_31032020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Promoter of Divi's Laboratories Limited has informed the Exchange regarding Disclosure under Regulation 30  of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011","15-Apr-2020 08:57:00","2020-04-15 08:57:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_15042020085759_DivisLaboratoriesLimited.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Update from Divi s Labs related to COVID-19: Operations, measures put in place, support to the nation - Press Release'.","01-Apr-2020 14:37:00","2020-04-01 14:37:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_01042020143713_Press_Release_Divis_SE_01042020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","31-Mar-2020 12:09:00","2020-03-31 12:09:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31032020120929_Trading_Window_Closure_31032020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","31-Mar-2020 12:02:00","2020-03-31 12:02:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31032020120256_Trading_Window_Closure_31032020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Intimation of commencement of commercial production from DCV-SEZ Unit'.","09-Mar-2020 10:17:00","2020-03-09 10:17:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_09032020101758_DCVSEZ_CommercialProduction_09032020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Postal Ballot. Further, the company has informed the Exchange regarding voting results.","27-Feb-2020 17:26:00","2020-02-27 17:26:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_27022020172605_PB_Voting_Results_27022020_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement - Notice of Record date for interim dividend '.","13-Feb-2020 14:14:00","2020-02-13 14:14:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_13022020141403_NewspaperRecordDateNotice_Reg30_Divis_13022020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Record Date","Divi's Laboratories Limited has informed the Exchange that the Company has fixed Record Date as February 26, 2020 for the purpose of Interim dividend","12-Feb-2020 16:32:00","2020-02-12 16:32:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_12022020163253_DIVISLAB_12022020162547.pdf"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on February 12, 2020, declared Interim Dividend of 16 per equity share.","12-Feb-2020 16:25:00","2020-02-12 16:25:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_12022020162547_Outcome_Interim_Dividend_12022020_Divis.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","07-Feb-2020 12:38:00","2020-02-07 12:38:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_07022020123805_Intimation_BoardMeeting_12022020_DivisLab.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on February 05, 2020.","05-Feb-2020 19:40:00","2020-02-05 19:40:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_05022020194010_Results_Q3SE_Submission_DLL.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.","05-Feb-2020 19:23:11","2020-02-05 19:23:11","-","-","https://nsearchives.nseindia.com/corporate/Results_Q3SE_Submission_DLL_05022020192311.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'US-FDA Inspection of Unit -II at Village Chippada, Andhra Pradesh'.","31-Jan-2020 17:52:00","2020-01-31 17:52:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31012020175234_Intimation_USFDA_31012020.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement confirming despatch of Postal Ballot Notice dated 04 January, 2020 and giving details of e-voting'.","28-Jan-2020 10:44:00","2020-01-28 10:44:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_28012020104351_Intimation_of_newspaper_publication28012020_postal_ballot_notice_018.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot","27-Jan-2020 09:31:00","2020-01-27 09:31:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_27012020092947_Intimation_of_Postal_Ballot_Notice_04012020_014.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 December, 2019'.","20-Jan-2020 09:26:00","2020-01-20 09:26:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_20012020092546_Certificate_74_5_31122019DIVIS_014.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on January 04, 2020.","04-Jan-2020 13:09:00","2020-01-04 13:09:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_04012020130659_OutcomeofBoardMeeting04012020DIVISLABS_026.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","31-Dec-2019 08:50:00","2019-12-31 08:50:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31122019084930_Tradingwindowclosure31122019Divis_007.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Change of name of the Share Transfer Agent of the Company from  KARVY FINTECH PRIVATE LIMITED  to  KFIN TECHNOLOGIES PRIVATE LIMITED'.","10-Dec-2019 09:58:00","2019-12-10 09:58:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_10122019095748_RTA_name_change_006.pdf"
"DIVISLAB","Divi's Laboratories Limited","Related Party Transactions","Divi's Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.","03-Dec-2019 12:55:00","2019-12-03 12:55:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_3122019124955_RPT30092019Divis_093.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates","18-Nov-2019 11:14:00","2019-11-18 11:14:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_18112019111314_Investors_Meet_105.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'US-FDA Inspection of Unit -I at village Lingojigudem, Bhuvanagiri Yadadri District, Telangana'.","15-Nov-2019 11:43:00","2019-11-15 11:43:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_15112019114254_cs15112019_091.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on November 05, 2019.","05-Nov-2019 18:36:00","2019-11-05 18:36:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_05112019182610_DIVISLAB_outcome_442.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.","05-Nov-2019 18:02:33","2019-11-05 18:02:33","-","-","https://nsearchives.nseindia.com/corporate/Q2results30092019DIVIS_05112019180233.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Newspaper publication- Notice for Issue of duplicate share certificate'.","22-Oct-2019 15:53:00","2019-10-22 15:53:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_22102019155308_Newspaper_publication_Notice_for_Issue_of_duplicate_share_certificate_220.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 September, 2019'.","22-Oct-2019 14:40:00","2019-10-22 14:40:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_22102019144042_Certificate_reg74_5_30092019_Divis_162.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Postal Ballot. Further, the company has informed the Exchange regarding voting results.","09-Oct-2019 14:50:00","2019-10-09 14:50:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_09102019144801_PBresultsDivis09102019_151.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","27-Sep-2019 16:24:00","2019-09-27 16:24:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_27092019162353_TradingwindowClosure_333.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates","11-Sep-2019 12:14:00","2019-09-11 12:14:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_11092019121357_Intimation_Investor_Meet_091.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement confirming despatch of Postal Ballot Notice and e-voting details - published on 08 September 2019'.","09-Sep-2019 14:03:00","2019-09-09 14:03:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_09092019140238_IntimationOfNewsPaperAdDivis09092019_196.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement confirming despatch of Postal Ballot Notice and e-voting details'.","09-Sep-2019 13:53:00","2019-09-09 13:53:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_09092019135245_IntimationOfNewsPaperAdDivis09092019_192.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot","07-Sep-2019 10:50:00","2019-09-07 10:50:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_07092019104644_IntimationOfPostalBallot23082019DivisLabs_004.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Inspection of Unit-II by EMA'.Divi's Laboratories Limited, Unit-2 Vishakhapatnam has been inspected by 5 inspectors from HPRA (Ireland) and JAZMP (Slovenia) from 26th August, 2019 to                    30th August, 2019.The inspection at site was focused on general GMP.The inspection has concluded successfully with no critical observations.","30-Aug-2019 17:25:00","2019-08-30 17:25:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30082019172341_Update_EMA_Inspection_321.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Annual General Meeting held on August 23, 2019. Further, the company has informed the Exchange regarding voting results.","24-Aug-2019 14:13:00","2019-08-24 14:13:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_24082019141242_AGM_Voting_Results_and_ScrutinizersReport2019_DivisLab_021.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding  Board meeting held on August 23, 2019.","23-Aug-2019 18:50:00","2019-08-23 18:50:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_23082019184903_BoardMeeting_Outcome_23082019_329.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 23, 2019","23-Aug-2019 17:43:00","2019-08-23 17:43:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_23082019174232_Out_come_of_AGM_Divis_23082019_280.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates","21-Aug-2019 12:12:00","2019-08-21 12:12:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_21082019121136_Intimationofanalystmeet_061.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates","21-Aug-2019 09:58:00","2019-08-21 09:58:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_21082019095820_Intimation_Analyst_investor_meet_015.pdf"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates","21-Aug-2019 09:54:00","2019-08-21 09:54:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_21082019095402_Intimation_Axis_capital_meeting_013.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Compliance of Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","20-Aug-2019 11:45:00","2019-08-20 11:45:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_20082019114445_Intimation_Reg30_044.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Revised Press Release on the financials of the Company for the quarter ended 30th June 2019 '.","10-Aug-2019 15:25:00","2019-08-10 15:25:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_10082019152156_Revised_Press_Release_097.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.","10-Aug-2019 14:35:18","2019-08-10 14:35:18","-","-","https://nsearchives.nseindia.com/corporate/Financial_Results_30062019_Divis_10082019143518.zip"
"DIVISLAB","Divi's Laboratories Limited","Appointment","Divi's Laboratories Limited has informed the Exchange regarding Appointment of Mr M Satish Choudhury as Company Secretary & Compliance Officer of the company w.e.f. August 10, 2019.","10-Aug-2019 14:31:00","2019-08-10 14:31:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_10082019143113_IntimationCSappt_068.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Newspaper Publication - Notice of 29th Annual General Meeting, Remote E-Voting and Book Closure Information '.","27-Jul-2019 12:54:00","2019-07-27 12:54:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_27072019125333_AGMnewspaperad_27072019_Divis_028.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 23, 2019","25-Jul-2019 13:38:00","2019-07-25 13:38:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_25072019133809_AnnualReport_2018_19DIVIS_113.pdf"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi's Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from August 17, 2019 to August 23, 2019 ( both days inclusive) for the purpose of Annual General Meeting and payment of dividend.","25-Jul-2019 09:56:00","2019-07-25 09:56:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract3_25072019095235_DIVISLAB_017.pdf"
"DIVISLAB","Divi's Laboratories Limited","Change in Company Secretary/Compliance Officer","Divi's Laboratories Limited has informed the Exchange about appointment of Mr. M. Satish Choudhury as Compliance Officer of the Company in place of interim Compliance Officer Ms. Deepa Kumari with effect from 19 July, 2019.","19-Jul-2019 16:58:00","2019-07-19 16:58:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_19072019165703_Reg_30_Compaliance_Officer_231.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Notice given to shareholders in respect of transfer of equity shares to IEPF Account by Newspaper advertisement on 13 July 2019 in the following newspapers:ￂﾕ Financial Express (English Daily)ￂﾕ Andhra Prabha (Telugu Daily)'.","13-Jul-2019 10:57:00","2019-07-13 10:57:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_13072019105258_Reg30IEPFnewspaperDivisLabs_003.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 from July 01, 2019 till 48 hours after the declaration of the financial results for the quarter ended June 30, 2019.","27-Jun-2019 16:19:00","2019-06-27 16:19:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_27062019161628_Trading_Window_Closure_180.pdf"
"DIVISLAB","Divi's Laboratories Limited","Related Party Transactions","Divi's Laboratories Limited has submitted to the Exchange a copy of revised half yearly Disclosure on Related Party Transactions for the period ended March 31, 2019.","17-Jun-2019 10:26:00","2019-06-17 10:26:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_1762019892_Reg_RPT_23_9_Revised_079.pdf"
"DIVISLAB","Divi's Laboratories Limited","Related Party Transactions","Divi's Laboratories Limited has submitted to the Exchange a copy of half yearly Disclosure on Related Party Transactions for the half year ended March 31, 2019.","17-Jun-2019 09:46:00","2019-06-17 09:46:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_176201983051_RPT_Reg_29_3_053.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'US-FDA Inspection of Unit -II at Village Chippada, Andhra Pradesh' Diviￂﾒs Laboratories hereby announces that its Unit-II at village Chippada, Bheemunipatnam District, Andhra Pradesh has had an inspection by the US-FDA from 10th June 2019 to 15th June, 2019. This was a general cGMP inspection by the US-FDA. The inspection has been concluded with no 483 observations.","15-Jun-2019 15:17:00","2019-06-15 15:17:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_15062019151719_US_FDA_Inspection_040.pdf"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its Meeting held on May 25, 2019 has recommended dividend@ 800% i.e Rs. 16/- per equity share of face valueRs. 2/- each for the financial year 2018-19.","27-May-2019 09:29:00","2019-05-27 09:29:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_25052019152002_DIVISLAB_034.pdf"
"DIVISLAB","Divi's Laboratories Limited","Resignation","Divi's Laboratories Limited has informed the Exchange regarding Resignation of Mrs PV Lakshmi Rajani as Company Secretary & Compliance Officer of the company w.e.f. May 31, 2019.","25-May-2019 15:06:00","2019-05-25 15:06:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_25052019145933_Outcome_BM_085.pdf"
"DIVISLAB","Divi's Laboratories Limited","Appointment","Divi's Laboratories Limited has informed the Exchange regarding Appointment of Ms Deepa Kumari as Compliance Officer of the company w.e.f. Jun 01, 2019.","25-May-2019 15:06:00","2019-05-25 15:06:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_25052019150430_Outcome_BM_086.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.","25-May-2019 14:50:05","2019-05-25 14:50:05","-","-","https://nsearchives.nseindia.com/corporate/Audited_Financial_Results_31032019_25052019145005.zip"
"DIVISLAB","Divi's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","The Promoter along with PAC has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019.","08-Apr-2019 15:19:00","2019-04-08 15:19:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_08042019132102_Divi_258.pdf"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","03-Apr-2019 11:28:00","2019-04-03 11:28:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_03042019112751_Trading_window_closure_059.pdf"
"DIVISLAB","Divi's Laboratories Limited","Code of Conduct under SEBI(PIT) Reg., 2015","Divi's Laboratories Limited has informed the Exchange regarding the Code of Conduct under SEBI(PIT) Reg., 2015","28-Mar-2019 16:30:00","2019-03-28 16:30:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_28032019162804_Code_of_fair_disclosure_158.pdf"
"DIVISLAB","Divi's Laboratories Limited","Appointment","Divi's Laboratories Limited has informed the Exchange regarding Appointment of Ms Prof Sunaina Singh as Additional ( Independent) Director of the company w.e.f. March 28, 2019.","28-Mar-2019 13:16:00","2019-03-28 13:16:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_28032019131524_Outcome_BM_069.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Postal Ballot. Further, the company has informed the Exchange regarding voting results.","18-Mar-2019 15:48:00","2019-03-18 15:48:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_18032019154633_Postal_Ballot_Voting_Results_114.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Update on Income Tax raids at Company's offices'.","19-Feb-2019 13:24:00","2019-02-19 13:24:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_19022019132320_Updates_075.pdf"
"DIVISLAB","Divi's Laboratories Limited","News Verification","The Exchange has sought clarification from Divi's Laboratories Limited with respect to recent news item captioned ￂﾓ Income Tax Raids conducted at Coￂﾒs offices in Telengana & Andhra Pradesh ￂﾔ. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Divi's Laboratories Limited has submitted their response.","18-Feb-2019 18:51:00","2019-02-18 18:51:00","-","-","https://nsearchives.nseindia.com/corporate/mjain_18022019184042_DIVISLAB_7940_reply_266.pdf"
"DIVISLAB","Divi's Laboratories Limited","News Verification","The Exchange has sought clarification from Divi's Laboratories Limited with respect to recent news item captioned ""Income Tax Raids conducted at Co's offices in Telengana & Andhra Pradesh"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","15-Feb-2019 11:18:00","2019-02-15 11:18:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement confirming dispatch of Postal Ballot Notice '.","15-Feb-2019 10:48:00","2019-02-15 10:48:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_15022019104658_Newpaper_AD_024.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot","14-Feb-2019 11:33:00","2019-02-14 11:33:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_14022019112958_Postal_Ballot_Notice_049.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on February 02, 2019.","02-Feb-2019 15:52:00","2019-02-02 15:52:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract3_02022019153235_DIVISLAB_outcome_163.pdf"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on February 02, 2019.","02-Feb-2019 13:34:00","2019-02-02 13:34:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_02022019133322_Outcome_of_BM_02022019_067.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.","02-Feb-2019 13:24:12","2019-02-02 13:24:12","-","-","https://nsearchives.nseindia.com/corporate/Unaudited_financial_results_31122018_02022019132412.zip"
"DIVISLAB","Divi's Laboratories Limited","Registrar & Share Transfer Agent Update","Divi's Laboratories Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update","03-Dec-2018 11:30:00","2018-12-03 11:30:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_03122018113015_RTA_update_122.pdf"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.","27-Oct-2018 14:33:47","2018-10-27 14:33:47","-","-","https://nsearchives.nseindia.com/corporate/Unaudited_Financial_Results_30092018_27102018143347.zip"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Annual General Meeting held on September 10, 2018. Further, the company has informed the Exchange regarding voting results.","11-Sep-2018 12:30:00","2018-09-11 12:30:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_11092018122835_AGM_Voting_Results_058.pdf"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 10, 2018","10-Sep-2018 14:22:00","2018-09-10 14:22:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_10092018142013_AGM_OUTCOME10092018_347.pdf"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement confirming dispatch of Notice of 28th Annual General Meeting '.","07-Aug-2018 12:31:00","2018-08-07 12:31:00","-","-","https://nsearchives.nseindia.com/corporate/Newspaperadd_07082018123126_704.zip"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 10, 2018","06-Aug-2018 14:15:00","2018-08-06 14:15:00","-","-","https://nsearchives.nseindia.com/corporate/Notice_AGM2018_06082018141525_148.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.","04-Aug-2018 12:57:30","2018-08-04 12:57:30","-","-","https://nsearchives.nseindia.com/corporate/Unaudited_Financial_Results_30062018_04082018125730.zip"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi's Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from  September 4, 2018 to September 10, 2018 (both days inclusive) for  the purpose of the Annual General Meeting going to be held on September 10, 2018 and payment of dividend, if declared at the ensuing Annual General Meeting.","30-Jul-2018 12:51:00","2018-07-30 12:51:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation_of_BookClosure_30072018125145_847.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies of notice to shareholders of the company intimating that equity shares in respect of which dividend remain unclaimed for seven consecutive years would be transferred to Investor Education and Protection Fund (IEPF) Authority. This notice was published on 4th July, 2018 in the following newspapers:ￂﾕ Financial Express (English Daily)ￂﾕ Andhra Prabha (Telugu Daily)'.","04-Jul-2018 12:44:00","2018-07-04 12:44:00","-","-","https://nsearchives.nseindia.com/corporate/Notice_04072018124421_394.zip"
"DIVISLAB","Divi's Laboratories Limited","Auditor's report","Divi's Laboratories Limited has informed the Exchange regarding Auditors report for the period ended March 31, 2018","26-May-2018 21:05:00","2018-05-26 21:05:00","-","-","https://nsearchives.nseindia.com/corporate/AuditReport_on_Annual_FinancialResults_31032018_26052018210504_853.zip"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 26, 2018 has recommended dividend @ 500 % i.e Rs. 10 /- per equity share of face value Rs. 2 /- each for the financial year 2017-18, subject to approval of the member in the ensuing Annual General Meeting (AGM).","26-May-2018 15:19:00","2018-05-26 15:19:00","-","-","https://nsearchives.nseindia.com/corporate/Divilabs_26052018151956.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.","26-May-2018 14:37:47","2018-05-26 14:37:47","-","-","https://nsearchives.nseindia.com/corporate/Audited_Financial_Results_31032018_26052018143747.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Diviￂﾒs Laboratories hereby announces that its Unit-I at Choutuppal, Telangana State has had an inspection by the US-FDA from 14th May 2018 to 16th May, 2018. This was a general cGMP inspection by the FDA. The inspection has been concluded with no 483 observations.'.","16-May-2018 16:32:00","2018-05-16 16:32:00","-","-","https://nsearchives.nseindia.com/corporate/Announcement_USFDA_Inspection_16052018163227_349.zip"
"DIVISLAB","Divi's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","Dr. Murali K. Divi has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","07-Apr-2018 12:06:00","2018-04-07 12:06:00","-","-","https://nsearchives.nseindia.com/corporate/divis_07042018120606.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.","27-Jan-2018 17:39:56","2018-01-27 17:39:56","-","-","https://nsearchives.nseindia.com/corporate/Unaudited_financialresults_31122017_27012018173956.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'We had earlier informed the Exchanges that the companyￂﾒs Unit-II at Visakhapatnam was inspected by US-FDA in September, 2017 wherein a Form-483 was issued with 6 observations.In this regard, we wish to inform you that we have now received an Establishment Inspection Report (EIR) from US-FDA for our Unit-II, as closure of audit by FDA.'.","18-Nov-2017 12:05:00","2017-11-18 12:05:00","-","-","https://nsearchives.nseindia.com/corporate/Update_on_USFDA_inspection_18112017120553_396.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'We had earlier informed the Exchanges vide our letter of 2nd November, 2017 that the US-FDA will be lifting the Import Alert 66-40 imposed on the companyￂﾒs Unit-II at Visakhapatnam.The FDAￂﾒs website has now been updated on 14th November, 2017 and the Import Alert 66-40 on the companyￂﾒs Unit-II has been removed'.","15-Nov-2017 08:44:00","2017-11-15 08:44:00","-","-","https://nsearchives.nseindia.com/corporate/Update_US_FDA_15112017084447_263.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Further to our letter dated 2nd November, 2017, Diviￂﾒs Laboratories has been informed by the US-FDA that the Agency has completed evaluation of the Companyￂﾒs corrective actions in response to FDAￂﾒs Warning Letter: 320-17-34 dated April 13, 2017.  We also note from the update on FDAￂﾒs website that they have closed-out the warning letter.'.","10-Nov-2017 09:07:00","2017-11-10 09:07:00","-","-","https://nsearchives.nseindia.com/corporate/Update_US_FDA_10112017090715_022.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Diviￂﾒs Laboratories has been informed by the US-FDA that it will be lifting the Import Alert 66-40 and moving to close out the Warning letter issued to the companyￂﾒs Unit-II at Visakhapatnam.'.","02-Nov-2017 08:38:00","2017-11-02 08:38:00","-","-","https://nsearchives.nseindia.com/corporate/Updates_US_FDA_02112017083839_297.zip"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2017.","31-Oct-2017 18:54:00","2017-10-31 18:54:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31102017185403.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.","31-Oct-2017 18:41:31","2017-10-31 18:41:31","-","-","https://nsearchives.nseindia.com/corporate/Unaudited_Results_30092017_31102017184131.zip"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Annual General Meeting held on September 25, 2017. Further, the company has informed the Exchange regarding voting results.","26-Sep-2017 14:39:00","2017-09-26 14:39:00","-","-","https://nsearchives.nseindia.com/corporate/AGM_Voting_Results_26092017143938_170.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'Chairman's Speech'.","25-Sep-2017 17:00:00","2017-09-25 17:00:00","-","-","https://nsearchives.nseindia.com/corporate/Chairman_Speech_2017_25092017170056_272.zip"
"DIVISLAB","Divi's Laboratories Limited","Shareholders meeting","Divi's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2017","25-Sep-2017 15:14:00","2017-09-25 15:14:00","-","-","https://nsearchives.nseindia.com/corporate/AGM_Proceedings_25092017151454_194.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding 'We wish to inform that Diviￂﾒs Laboratories Limited, Unit-2 has been inspected by US-FDA from September 11 to September 19, 2017.This inspection was for full cGMP and verification of all Corrective Actions proposed against the previous Inspection observations. Diviￂﾒs Laboratories Limited announces that all previous observations have been confirmed as completed and resolved. On completion of this inspection, Diviￂﾒs Laboratories Limited has received a Form 483 citing six observations which are procedural and the company will be responding to these within the stipulated time.Disclaimer:This is to inform that the statements in this document relating to the estimates or events may be ￂﾓforward looking statementsￂﾔ within the meaning of the applicable securities regulations. Actual results, performance or events, financial or non-financial, could differ materially from those expressed or implied.'.","20-Sep-2017 10:52:00","2017-09-20 10:52:00","-","-","https://nsearchives.nseindia.com/corporate/Update_20092017105232_056.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding ' Notice of the 27th Annual General Meeting of the Company scheduled to be held on Monday, the 25th day of September 2017 at 10.00 A.M. at Global Peace Auditorium, Brahma Kumaris, Shanti Sarovar, Academy for Better World, Gachibowli, Hyderabad   500 032. '.","30-Aug-2017 10:21:00","2017-08-30 10:21:00","-","-","https://nsearchives.nseindia.com/corporate/Notice_of_27th_AGM_30082017102159_243.zip"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi's Laboratories Limited has informed the Exchange that The Register of Members and Share Transfer Books of the Company will remain closed from  September 19, 2017 to  September 25, 2017 (both days inclusive) for the purpose of the Annual General Meeting of the Company and payment of dividend, if declared at the ensuing Annual General Meeting to be held on September 25, 2017.","21-Aug-2017 11:32:00","2017-08-21 11:32:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_21082017113233.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange that Divi s Laboratories Limited, Unit-2 Vishakhapatnam has been inspected by 5 inspectors from HPRA (Ireland) and JAZMP (Slovenia) from July 31, 2017 to August 4, 2017. The inspection was focused on: 1) Follow up on the effectiveness of the CAPA s implemented from the last JAZMP inspection 2) General GMP inspection of the site The inspection has concluded successfully with no critical observations.","04-Aug-2017 14:47:00","2017-08-04 14:47:00","-","-","https://nsearchives.nseindia.com/corporate/EMA_Announcement_04082017144706_264.zip"
"DIVISLAB","Divi's Laboratories Limited","Appointment","Divi's Laboratories Limited has informed the Exchange regarding Appointment of Mr S. Ganapaty as Additional ( Independent) Director of the company w.e.f. July 22, 2017.","22-Jul-2017 15:22:00","2017-07-22 15:22:00","-","-","https://nsearchives.nseindia.com/corporate/Outcome_Of_BM_22072017152208_051.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2017.","22-Jul-2017 13:49:20","2017-07-22 13:49:20","-","-","https://nsearchives.nseindia.com/corporate/Unaudited_Results_30062017_22072017134920.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding USFDA to Lift Import Alert 99-32 on the Company's Unit-II at Visakhapatnam.","10-Jul-2017 11:57:00","2017-07-10 11:57:00","-","-","https://nsearchives.nseindia.com/corporate/FDA_Updates_10072017115719_114.zip"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 27, 2017.Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors at their meeting held on 27th June, 2017 has:1) Noted the completion of tenure of Mrs. S. Sridevi as an Independent Director of the company w.e.f. 22nd June, 2017 and hence she ceases to be a director of the company.  The Board places on record its appreciation of the contribution made by Mrs. Sridevi during her tenure.2) Appointed Dr. Ramesh B. V. Nimmagadda as an Additional (Independent) Director w.e.f. 27th June, 20173) Appointed Ms. Nilima Motaparti, as an Additional (Whole-time) Director w.e.f. 27th June, 2017, who was earlier appointed by the members as Chief Controller (Commercial) in the year 2012.4) Noted that the term of the present Statutory Auditors M/s. PVRK Nageswara Rao & Co., expires at the conclusion of the ensuing 27th Annual General Meeting of the company as per Section 139 of the Companies Act, 2013, and are not eligible for re-appointment.5) Recommended appointment of M/s. Price Waterhouse, Chartered Accountants, as Statutory Auditors of the company for a term of 5 consecutive years from the conclusion of the 27th Annual General Meeting of the Company scheduled to be held in the year 2017 till the conclusion of 32nd Annual General Meeting, for approval of the members of the company.","28-Jun-2017 10:52:00","2017-06-28 10:52:00","-","-","https://nsearchives.nseindia.com/corporate/Appointment_Directors_and_Auditors_28062017105211_312.zip"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 26, 2017, recommended Final Dividend of Rs. 10 per equity share.","26-May-2017 18:16:00","2017-05-26 18:16:00","-","-","https://nsearchives.nseindia.com/corporate/AuditedFinancialResults31032017_26052017181655_951.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2017.","26-May-2017 18:06:03","2017-05-26 18:06:03","-","-","https://nsearchives.nseindia.com/corporate/AuditedFinancialResults31032017_26052017180603.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange that Further to Company's earlier communication dated April 08, 2017 to the Stock Exchanges, Company wish to update that the US-FDA has issued a Warning Letter for the company's Unit-II at Visakhapatnam.","22-Apr-2017 16:37:00","2017-04-22 16:37:00","-","-","https://nsearchives.nseindia.com/corporate/WaringLetter_22042017163738_539.zip"
"DIVISLAB","Divi's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","Dr. Murali Divi has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","10-Apr-2017 19:25:00","2017-04-10 19:25:00","-","-","https://nsearchives.nseindia.com/corporate/divilabs_10042017192540.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange that the US-FDA has exempted some more products manufactured at the company's Unit-II at Visakhapatnam from the Import Alert issued under clauses 66-40 & 99-32 of the FDA regulations.","08-Apr-2017 14:59:00","2017-04-08 14:59:00","-","-","https://nsearchives.nseindia.com/corporate/UpdateonImportAlert_08042017145939_421.zip"
"DIVISLAB","Divi's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates","24-Mar-2017 18:09:00","2017-03-24 18:09:00","-","-","https://nsearchives.nseindia.com/corporate/ConCallNotice_24032017180908_323.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange regarding update that the Import Alert by US-FDA for the products manufactured at the company's Unit-II at Visakhapatnam , Andhra Pradesh.","22-Mar-2017 16:39:00","2017-03-22 16:39:00","-","-","https://nsearchives.nseindia.com/corporate/UPDATEonimportalert_22032017163927_948.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange vide letter dated March 21, 2017 regarding "" Import Alert 66-40 issued by US-FDA on products manufactured at the company's Unit -II at Visakhapatnam, Andhra Pradesh"".","21-Mar-2017 08:51:00","2017-03-21 08:51:00","-","-","https://nsearchives.nseindia.com/corporate/AnnouncementonImportAlert_21032017085120_373.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2016.","04-Feb-2017 11:45:48","2017-02-04 11:45:48","-","-","https://nsearchives.nseindia.com/corporate/UnauditedResults31122016_04022017114548.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange vide letter dated January 09, 2017, regarding ""Update on US-FDA inspection of our Unit-II at Visakhapatnam"".","09-Jan-2017 09:50:00","2017-01-09 09:50:00","-","-","https://nsearchives.nseindia.com/corporate/Updates_09012017095048_150.zip"
"DIVISLAB","Divi's Laboratories Limited","News Verification","The Exchange has sought clarification from Divi's Laboratories Limited with respect to recent news item captioned ""Emkay says on Vizag 483 observation: 1. Proper control not being exercised over computer system 2. Facility equipments not maintained to ensure purity quality strength 3. Documentation and records not maintained or inaccurate falsified."" The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Divi's Laboratories Limited has submitted their response.","23-Dec-2016 16:00:00","2016-12-23 16:00:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_6565_reply_23122016160028.zip"
"DIVISLAB","Divi's Laboratories Limited","News Verification","The Exchange has sought clarification from Divi's Laboratories Limited with respect to recent news item captioned ""Emkay says on Vizag 483 observation: 1. Proper control not being exercised over computer system 2. Facility equipments not maintained to ensure purity quality strength 3. Documentation and records not maintained or inaccurate falsified."" In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","23-Dec-2016 14:05:00","2016-12-23 14:05:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange that it s Unit-II at Visakhapatnam, Andhra Pradesh has had an inspection by the US-FDA from November 29, 2016 to December 06, 2016. The Company have been issued a form 483 with 5 observations and these shall be responded within the time permitted.","07-Dec-2016 16:23:00","2016-12-07 16:23:00","-","-","https://nsearchives.nseindia.com/corporate/DivisUSFDA_07122016162323_581.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has submitted to the Exchange a copy of the Notice sent to shareholders of the company in respect of transfer of equity shares of the company to Investor Education and Protection Fund (IEPF) Suspense Account, published in newspapers.","30-Nov-2016 10:51:00","2016-11-30 10:51:00","-","-","https://nsearchives.nseindia.com/corporate/LettertoSEs_30112016105132_369.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2016.","12-Nov-2016 12:12:36","2016-11-12 12:12:36","-","-","https://nsearchives.nseindia.com/corporate/Unauditedresults30092016_12112016121236.zip"
"DIVISLAB","Divi's Laboratories Limited","News Clarification","Divi's Laboratories Limited has informed the Exchange vide letter dated August 31, 2016 regarding ""Clarification on news on import alert from US FDA"".","31-Aug-2016 18:16:00","2016-08-31 18:16:00","-","-","https://nsearchives.nseindia.com/corporate/ClarificationLetter_31082016181620_932.zip"
"DIVISLAB","Divi's Laboratories Limited","Regulation 44(3) of SEBI (LODR), Reg., 2015","Divi's Laboratories Limited has submitted to the Exchange a copy of voting results of Annual General Meeting of the Company held on August 29, 2016, along with a copy of Scrutinizer's Report.","30-Aug-2016 16:00:00","2016-08-30 16:00:00","-","-","https://nsearchives.nseindia.com/corporate/AGMvotingresults_30082016160007_192.zip"
"DIVISLAB","Divi's Laboratories Limited","Annual General Meeting Updates","Divi's Laboratories Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on August 29, 2016 along with Chairman Speech.","29-Aug-2016 14:29:00","2016-08-29 14:29:00","-","-","https://nsearchives.nseindia.com/corporate/AGMproceedings_29082016142927_476.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated August 12, 2016 with respect to the Unaudited Financial Results for the Quarter ended June 30, 2016.","12-Aug-2016 18:16:00","2016-08-12 18:16:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_pres_12082016181652.zip"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange that the Board of Directors of the company, at their meeting held on August 12, 2016, have approved and ratified one-time ex-gratia of an aggregate amount of Rs.79 crores to the employees and whole-time directors of the company on the occasion of completion of 25 years of formation of the company. This amount will be reflected in the financial results for the 2nd quarter of the current financial year.","12-Aug-2016 18:14:00","2016-08-12 18:14:00","-","-","https://nsearchives.nseindia.com/corporate/outcome_12082016181420_306.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended June 30, 2016.","12-Aug-2016 17:55:44","2016-08-12 17:55:44","-","-","https://nsearchives.nseindia.com/corporate/Unauditedresults30062016_12082016175544.zip"
"DIVISLAB","Divi's Laboratories Limited","Annual General Meeting Updates","Divi's Laboratories Limited has submitted to the Exchange a copy of notice of Annual General Meeting of the members of the Company to be held on  August 29, 2016.","04-Aug-2016 10:17:00","2016-08-04 10:17:00","-","-","https://nsearchives.nseindia.com/corporate/NoticeOf26thAnnualGeneralMeeting_04082016101722_031.zip"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi's Laboratories Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from August 22, 2016 to August 26, 2016 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on August 29, 2016.","29-Jul-2016 13:53:00","2016-07-29 13:53:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_29072016135306.zip"
"DIVISLAB","Divi's Laboratories Limited","Declaration for audit reports with unmodified opinion(s)","Divi's Laboratories Limited has informed the Exchange regarding Declaration mentioned in SEBI Circular CIR/CFD/CMD/56/2016.","07-Jun-2016 13:54:00","2016-06-07 13:54:00","-","-","https://nsearchives.nseindia.com/corporate/Declaration_07062016135434_201.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release (Revised)","Divi's Laboratories Limited has informed the Exchange regarding a press release dated May 28, 2016 titled ""Divi's Labs earns a PAT of Rs. 1112 crores on consolidated basis for the year 2016"". (revised)","28-May-2016 14:54:00","2016-05-28 14:54:00","-","-","https://nsearchives.nseindia.com/corporate/RevisedPressRelease_28052016145445_069.zip"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 28, 2016 has recommended the interim dividend declared as final dividend for the year ended March 31, 2016.","28-May-2016 14:29:00","2016-05-28 14:29:00","-","-","https://nsearchives.nseindia.com/corporate/Divis_result_28052016142915.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated May 28, 2016, titled ""Divi's Labs earns a PAT of Rs 1112 crores on consolidated basis for the year 2016"".","28-May-2016 14:27:00","2016-05-28 14:27:00","-","-","https://nsearchives.nseindia.com/corporate/Divis_result_28052016142719.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended March 31, 2016.","28-May-2016 14:09:57","2016-05-28 14:09:57","-","-","https://nsearchives.nseindia.com/corporate/AuditedFinacialResults31032016_28052016140957.zip"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from May 21, 2016 to May 30, 2016 (both days inclusive) as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.","18-May-2016 12:18:00","2016-05-18 12:18:00","-","-","https://nsearchives.nseindia.com/corporate/Divis_18052016121824.zip"
"DIVISLAB","Divi's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","Dr. Murali K Divi has submitted to the Exchange vide letter dated April 04, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","04-Apr-2016 12:24:00","2016-04-04 12:24:00","-","-","https://nsearchives.nseindia.com/corporate/Divis_30_04042016122437.zip"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that the Board of Directors in its meeting held on March 10 2016 has declared an interim dividend @ Rs.10/- per equity share of face value of Rs.2/- each for the financial year 2015-16. The interim dividend will be credited / dispatched on or before March 29, 2016.","10-Mar-2016 13:00:00","2016-03-10 13:00:00","-","-","https://nsearchives.nseindia.com/corporate/OutcomeOfBM_10032016130059_840.zip"
"DIVISLAB","Divi's Laboratories Limited","Record Date","Divi's Laboratories Limited has informed the Exchange that the Company has fixed Record Date as March 18, 2016 for the purpose of interim dividend.","02-Mar-2016 15:06:00","2016-03-02 15:06:00","-","-","https://nsearchives.nseindia.com/corporate/DIVILAB_BM_02032016150626.zip"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from March 3, 2016 to March 12, 2016 (both days inclusive) as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.","02-Mar-2016 15:00:00","2016-03-02 15:00:00","-","-","https://nsearchives.nseindia.com/corporate/DIVILAB_BM_02032016150059.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange that it has had a successful inspection by the US-FDA for its Unit-2 at Chippada, Bheemunipatnam near Visakhapatnam during February, 2016 with no observations.","19-Feb-2016 16:04:00","2016-02-19 16:04:00","-","-","https://nsearchives.nseindia.com/corporate/NSE_19022016160424_402.zip"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 05 2016, has approved to shift the Registered Office of the Company from 7-1-77/E/1/303, Divi Towers, Dharam Karan Road, Ameerpet, Hyderabad 500 016 to 1-72/23(P)/DIVIS/303, Divi Towers, Cyber Hills, Gachibowli, Hyderabad 500 032 w.e.f February 05, 2016. The new Registered Office is within the local limits of the City.","05-Feb-2016 15:55:00","2016-02-05 15:55:00","-","-","https://nsearchives.nseindia.com/corporate/OutcomeofBMnse_05022016155557_161.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated February 05, 2016, titled, ""Divi's Labs earns a PAT of Rs.247 crores in Q3/FY16"".","05-Feb-2016 15:42:00","2016-02-05 15:42:00","-","-","https://nsearchives.nseindia.com/corporate/Divilab_press_05022016154203.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended December 31, 2015.","05-Feb-2016 15:37:46","2016-02-05 15:37:46","-","-","https://nsearchives.nseindia.com/corporate/UnauditedFinancialResults31122015Nse_05022016153746.zip"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from January 29, 2016 to February 07, 2016 (both days inclusive) as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.","27-Jan-2016 10:12:00","2016-01-27 10:12:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_27012016101220.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange that the Board of Director of the Company has appointed officials to determine materiality of an event or information and for the purpose of making disclosures to Stock Exchanges on which the Company's Securities are traded.","14-Dec-2015 08:30:00","2015-12-14 08:30:00","-","-","https://nsearchives.nseindia.com/corporate/LetterNSE_14122015083045_397.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated October 31, 2015 titled ""Divi's Labs earns a PAT of Rs.296 crores in Q2 of FY16"".","31-Oct-2015 13:47:00","2015-10-31 13:47:00","-","-","https://nsearchives.nseindia.com/corporate/divis_press_31102015134755.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2015.","31-Oct-2015 13:07:51","2015-10-31 13:07:51","-","-","https://nsearchives.nseindia.com/corporate/divi_31102015130751.zip"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from October 24, 2015 to November 2, 2015 (both days inclusive)","21-Oct-2015 10:59:00","2015-10-21 10:59:00","-","-","https://nsearchives.nseindia.com/corporate/Divilab_21102015105901.zip"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Securities","Divi's Laboratories Limited has informed the Exchange that Allotment Committee of Board of Directors in its meeting held on September 28, 2015 made the allotment of 13,27,34,290 equity shares of Rs.2/- each as Bonus Shares to the shareholders of the Company in the ratio of 1:1. Consequently, the paid-up equity share capital of the Company has increased to 26,54,68,580 equity shares from 13,27,34,290 equity shares of face value Rs. 2/- each.","28-Sep-2015 10:24:00","2015-09-28 10:24:00","-","-","https://nsearchives.nseindia.com/corporate/OutcomeOfAllotmentNSE_28092015102422_191.zip"
"DIVISLAB","Divi's Laboratories Limited","Record Date","Divi's Laboratories Limited has informed the Exchange that the Company has fixed Record Date as September 26, 2015 for the purpose of determining the eligibility of shareholders entitled to receive the Bonus shares.","14-Sep-2015 11:49:00","2015-09-14 11:49:00","-","-","https://nsearchives.nseindia.com/corporate/RecordDateIntimation_14092015114913_438.zip"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot Updates","Divi's Laboratories Limited has submitted to the Exchange the details of voting results of the Postal Ballot along with Report of Scrutinizer pursuant to clause 35A of the Listing Agreement.","14-Sep-2015 10:53:00","2015-09-14 10:53:00","-","-","https://nsearchives.nseindia.com/corporate/Clause35ANse_14092015105305_419.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Divi's Laboratories Limited has submitted to the Exchange the details of voting results of the Annual General Meeting of the Company held on August 31, 2015 along with Report of Scrutinizer pursuant to clause 35A of the Listing Agreement.","01-Sep-2015 16:23:00","2015-09-01 16:23:00","-","-","https://nsearchives.nseindia.com/corporate/Divi_35A_01092015162330.zip"
"DIVISLAB","Divi's Laboratories Limited","Annual General Meeting Updates","Divi's Laboratories Limited has informed the Exchange regarding the outcome of the Annual General Meeting of the company held on August 31, 2015.","31-Aug-2015 15:16:00","2015-08-31 15:16:00","-","-","https://nsearchives.nseindia.com/corporate/AGMOutcomeNSE_31082015151605_294.zip"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot Updates","Divi's Laboratories Limited has submitted to the Exchange a copy of the Postal Ballot Notice, Pursuant to Section 110 and other applicable provisions, if any, of the Companies Act, (the ""Act""), 2013 read together with the Companies ( Management and Administration) Rules, 2014.","14-Aug-2015 11:08:00","2015-08-14 11:08:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_pb_14082015110818.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated August 08, 2015 titled ""Divi's Labs earns a total income of Rs. 809 crores for Q1 of FY16"".","08-Aug-2015 13:08:00","2015-08-08 13:08:00","-","-","https://nsearchives.nseindia.com/corporate/divi_press_08082015130802.zip"
"DIVISLAB","Divi's Laboratories Limited","Bonus","Divi's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on August 08, 2015, the Board is pleased to recommend issue of Bonus equity shares in the ratio of 1:1 i.e., one (1) equity share for every one (1) equity share held as on a Record Date to be determined, subject to approval by the members of the company.","08-Aug-2015 13:00:00","2015-08-08 13:00:00","-","-","https://nsearchives.nseindia.com/corporate/divi_out_08082015130029.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2015.","08-Aug-2015 12:42:04","2015-08-08 12:42:04","-","-","https://nsearchives.nseindia.com/corporate/Divis_08082015124204.zip"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from August 1, 2015 to August 10, 2015 (both days inclusive) as per the Code of Conduct of the Company under the SEBI (Prohibition of lnsider Trading) Regulations, 2015.","30-Jul-2015 10:33:00","2015-07-30 10:33:00","-","-","https://nsearchives.nseindia.com/corporate/divis_30072015103330.zip"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi's Laboratories Limited has informed the Exchange that the Register of members and share transfer books of the Company will remain closed from August 10, 2015 to August 14, 2015(both days inclusive) for the purpose of Annual General Meeting of the Company and payment of Dividend, if declared at the ensuing Annual General Meeting.","20-Jul-2015 14:46:00","2015-07-20 14:46:00","-","-","https://nsearchives.nseindia.com/corporate/BookClosureNSE_20072015144604_310.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release (Revised)","Divi's Laboratories Limited has informed the Exchange vide letter dated May 23, 2015 regarding a revised press release titled ""Divi's Labs earns a PBT of Rs. 1072 crores on Total Income of Rs. 3115 crores on consolidated basis for the year 2015"".","23-May-2015 17:05:00","2015-05-23 17:05:00","-","-","https://nsearchives.nseindia.com/corporate/RevisedPressRelease31032015NSE_05232015170502_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Code of Conduct under SEBI(PIT) Reg., 2015","Divi's Laboratories Limited has informed the Exchange that In terms of Regulation 8 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and SEBI Circular referred above, further that the Company has formulated and adopted the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. The code has been uploaded on the Website of Company. Further pursuant to Regulation 9 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015, the Company has adopted the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders.","23-May-2015 15:47:00","2015-05-23 15:47:00","-","-","https://nsearchives.nseindia.com/corporate/divi_code_05232015154701_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Date of payment of dividend","Divi's Laboratories Limited has informed the Exchange that the dividend on Equity Shares, shall be paid within 30 (thirty) days from the conclusion of the ensuing Annual General Meeting.","23-May-2015 15:20:00","2015-05-23 15:20:00","-","-","https://nsearchives.nseindia.com/corporate/divilab_div_05232015152002_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 23, 2015 has recommended a dividend of 1000% i.e. Rs. 20/- per equity share of Rs. 2/- face value for the year ended March 31, 2015.","23-May-2015 15:17:00","2015-05-23 15:17:00","-","-","https://nsearchives.nseindia.com/corporate/divilab_div_05232015151702_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated May 23, 2015 titled ""Divi's Labs earns a PBT of Rs. 1072 crores on Total Income od Rs. 3115 crores on consolidated basis for the year 2015"".","23-May-2015 13:06:00","2015-05-23 13:06:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_press_05232015130601_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2015.","23-May-2015 13:03:02","2015-05-23 13:03:02","-","-","https://nsearchives.nseindia.com/corporate/divilab_05232015130301_.zip"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from May 16, 2015 to May 25, 2015 (both days inclusive) as per the Code of Conduct of the Company under the SEBI Prohibition of Insider Trading Regulations, 1992.","12-May-2015 12:43:00","2015-05-12 12:43:00","-","-","https://nsearchives.nseindia.com/corporate/divislab_05122015124301_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","Dr. Murali K. Divi has submitted to the Exchange vide letter dated April 03, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","13-Apr-2015 10:11:00","2015-04-13 10:11:00","-","-","https://nsearchives.nseindia.com/corporate/divislaboratoriesltd_drmuralikdivi0001_04132015101102_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Divi's Laboratories Limited has submitted to the Exchange a copy of result of Postal Ballot pursuant to clause 35A of the Listing Agreement along with Report of Scrutinizer.","20-Mar-2015 12:51:00","2015-03-20 12:51:00","-","-","https://nsearchives.nseindia.com/corporate/Clause35ANSE_03202015125101_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot Updates","Divi's Laboratories Limited has informed the Exchange that in continuation to the Company's earlier announcement dated 17.02.2015 with reference to the Postal Ballot Notice, the date of declaration of Postal Ballot results has been inadvertently mentioned as March 21, 2015 instead of March 20, 2015.     Accordingly, the date of declaration of Postal Ballot results should be taken as March 20, 2015.","23-Feb-2015 17:39:00","2015-02-23 17:39:00","-","-","https://nsearchives.nseindia.com/corporate/CoveringLetterNSE_02232015173902_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot Updates","Divi's Laboratories Limited has submitted to the Exchange a copy of the Postal Ballot Notice, pursuant to Section 110 of the Companies Act, 2013.","17-Feb-2015 09:43:00","2015-02-17 09:43:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_postal_02172015094302_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi\'s Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 31-Dec-2014.","31-Jan-2015 14:11:05","2015-01-31 14:11:05","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31Dec_S_LR_01312015141102_.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated January 31, 2015 titled ""Divi's Labs earns a PAT of Rs. 221 crores in Q3/FY15"".","31-Jan-2015 13:54:00","2015-01-31 13:54:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_press_01312015135402_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange that ""The company is considering setting up a third manufacturing site to augment capacities besides derisking its business. We made an application to the Govt. of Andhra Pradesh for allotment of land near Kakinada and the company is awaiting favourable response. The company proposes to make an initial investment of Rs.500 crores on this facility.""","31-Jan-2015 12:57:00","2015-01-31 12:57:00","-","-","https://nsearchives.nseindia.com/corporate/AnnouncementNSE_01312015125701_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from January 24, 2015 to February 2, 2015 (both days inclusive) as per the Code of Conduct of the Company under the SEBI Prohibition of Insider Trading Regulations, 1992.","21-Jan-2015 16:45:00","2015-01-21 16:45:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_BM_01212015164502_2.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2014.","03-Nov-2014 08:31:03","2014-11-03 08:31:03","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30092014_S_LR_11032014083102_.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated November 01, 2014 titled "" Divi's Labs earns a PAT of Rs 230 crores in Q2 of FY15"".","03-Nov-2014 08:08:00","2014-11-03 08:08:00","-","-","https://nsearchives.nseindia.com/corporate/DIVIS_11032014080801_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Trading Window","Divi's Laboratories Limited has informed the Exchange that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the company from October 25, 2014 to November 03, 2014 (both days inclusive) as per the Code of Conduct of the Company under the SEBI Prohibition of Insider Trading Regulations, 1992.","22-Oct-2014 11:16:00","2014-10-22 11:16:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Annual General Meeting Updates","Divi's Laboratories Limited has informed the Exchange regarding Outcome of Annual General Meeting held on August 25, 2014.","26-Aug-2014 18:08:00","2014-08-26 18:08:00","-","-","https://nsearchives.nseindia.com/corporate/divi_outcome_08262014180802_3.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Divi's Laboratories Limited has submitted to the Exchange details of voting results pursuant to Clause 35A of the Listing Agreement.","26-Aug-2014 17:44:00","2014-08-26 17:44:00","-","-","https://nsearchives.nseindia.com/corporate/Clause35A_08262014174402_2.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated August 11, 2014, titled ""Divi's Labs earns a PAT of Rs.168 crores for Q1 of FY15"".","12-Aug-2014 08:56:00","2014-08-12 08:56:00","-","-","https://nsearchives.nseindia.com/corporate/DIVI_PR_08122014085603_2.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2014.","11-Aug-2014 18:43:02","2014-08-11 18:43:02","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB30062014_08112014184302_.zip"
"DIVISLAB","Divi's Laboratories Limited","Date of payment of dividend","Divi's Laboratories Limited has informed the Exchange that the dividend, when declared at the Annual General Meeting, will be credited / dispatched on or before September 08, 2014.","17-Jul-2014 12:28:00","2014-07-17 12:28:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi's Laboratories Limited has informed the Exchange that the Company has fixed Book Closure from August 4, 2014 to August 8, 2014 (both days inclusive) for the purpose of the Annual General Meeting of the Company scheduled to be held on August 25, 2014 and payment of dividend, if declared at the ensuing Annual General Meeting. Dividend, when declared at the Annual General Meeting, will be credited / dispatched on or before September 08, 2014. Further, in compliance with Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules 2014 and Clause 35B of the Listing Agreement the Company is providing e-voting facility to its members in respect of the businesses to be transacted at the Annual General Meeting. The voting rights of the Members shall be in proportion to the paid-up value of their shares in the equity capital of the Company as on the cut-off date, being July 25, 2014.","16-Jul-2014 18:36:00","2014-07-16 18:36:00","-","-","https://nsearchives.nseindia.com/corporate/BookclosureNSE_07162014183601_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated July 11, 2014 a copy of disclosure pursuant to Regulation 13(2), 13(2A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","14-Jul-2014 08:20:00","2014-07-14 08:20:00","-","-","https://nsearchives.nseindia.com/corporate/FormBNSE_07142014082002_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Change in Director(s)","Divi's Laboratories Limited has informed the Exchange regarding Changes in Directors.","23-Jun-2014 18:24:00","2014-06-23 18:24:00","-","-","https://nsearchives.nseindia.com/corporate/LetterNSE_06232014182402_3.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange that the Company is glad to announce that it has had a successful inspection by the US-FDA from 16th to 20th June, 2014, without any observations, for its Unit-1 at vill. Lingojigudem, Choutuppal Mandal near Hyderabad during this month. The purpose of this inspection was for general cGMP (Current Good Manufacturing Practices) for the facility.","20-Jun-2014 16:32:00","2014-06-20 16:32:00","-","-","https://nsearchives.nseindia.com/corporate/AnnouncementNSE_06202014163202_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi's Laboratories Limited has informed the Exchange that it has had an inspection by the US-FDA, with no major observations, for its Unit-II at vill. Chippada, Bheemunipatnam Mandal, near Visakhapatnam during June, 2014. The audit concluded with one observation primarily about further improvement of existing procedure. The purpose of this inspection was for Custom manufactured product.","06-Jun-2014 18:00:00","2014-06-06 18:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2014.","26-May-2014 10:23:02","2014-05-26 10:23:02","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31Mar2014_B_05262014102301_.zip"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 24, 2014 has recommended a dividend of 1000% i.e. Rs. 20/- per equity share of Rs. 2/- face value for the year ended March 31, 2014.","26-May-2014 08:32:00","2014-05-26 08:32:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated May 24, 2014, titled""Divi's Labs earns a consolidated Total Income of Rs.2532 crores in FY14"".","26-May-2014 08:08:00","2014-05-26 08:08:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_PR_26052014_05262014080802_3.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Divi's Laboratories Limited has informed the Exchange regarding results of the Postal Ballot  pursuant to clause 35A of the Listing Agreement.","05-May-2014 17:40:00","2014-05-05 17:40:00","-","-","https://nsearchives.nseindia.com/corporate/Clause35A_05052014174002_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated April 26, 2014 a copy of disclosure pursuant to Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","28-Apr-2014 11:20:00","2014-04-28 11:20:00","-","-","https://nsearchives.nseindia.com/corporate/FormD_04282014112002_2.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated April 23, 2014 a copy of disclosure pursuant to Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","23-Apr-2014 11:24:00","2014-04-23 11:24:00","-","-","https://nsearchives.nseindia.com/corporate/FormD_04232014112401_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated April 07, 2014 a copy of disclosure pursuant to Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","07-Apr-2014 16:00:00","2014-04-07 16:00:00","-","-","https://nsearchives.nseindia.com/corporate/FormD_04072014160003_3.zip"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot Updates","Divi's Laboratories Limited has submitted to the Exchange a copy of the Notice of Postal Ballot, pursuant to Section 192A(2) of the Companies Act, 1956 read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2011.","04-Apr-2014 14:20:00","2014-04-04 14:20:00","-","-","https://nsearchives.nseindia.com/corporate/DIVILAB_PB_04042014_04042014142001_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated March 11, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","11-Mar-2014 10:20:00","2014-03-11 10:20:00","-","-","https://nsearchives.nseindia.com/corporate/FormD_03112014102001_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated March 04, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","04-Mar-2014 14:24:00","2014-03-04 14:24:00","-","-","https://nsearchives.nseindia.com/corporate/FormD_03042014142401_2.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated February 26, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","26-Feb-2014 14:48:00","2014-02-26 14:48:00","-","-","https://nsearchives.nseindia.com/corporate/FormD_02262014144801_2.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated February 10, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","10-Feb-2014 14:48:00","2014-02-10 14:48:00","-","-","https://nsearchives.nseindia.com/corporate/FormD_02102014144801_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding press release, titled ""Divi's Labs earns a PAT of Rs.219 crores in Q3 of FY14"".","04-Feb-2014 08:28:00","2014-02-04 08:28:00","-","-","https://nsearchives.nseindia.com/corporate/DIVIS_pr_04022014_02042014082801_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the exchange the standalone financial results for the period ended 31-dec-2013.","03-Feb-2014 18:03:02","2014-02-03 18:03:02","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31dec2013_S_02032014180302_.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated January 27, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","27-Jan-2014 12:56:00","2014-01-27 12:56:00","-","-","https://nsearchives.nseindia.com/corporate/FormD-NSE_01272014125601_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under Insider Trading Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated January 04, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","06-Jan-2014 10:04:00","2014-01-06 10:04:00","-","-","https://nsearchives.nseindia.com/corporate/FormD-NSE_01062014100402_4.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the exchange the standalone financial results for the period ended 30-sep-2013.","08-Nov-2013 17:31:02","2013-11-08 17:31:02","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30sep2013_S_11082013173102_.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Divi's Laboratories Limited has informed the Exchange regarding the details of Voting results at the Annual General Meeting of the Company held on August 05, 2013, under Clause 35A.","06-Aug-2013 10:32:00","2013-08-06 10:32:00","-","-","https://nsearchives.nseindia.com/corporate/DIVILAB_disc35A_06082013_08062013103202_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Divi'S Laboratories Limited has informed the Exchange regarding details of Voting Results of Annual General Meeting of the Company held on August 05, 2013 pursuant to clause 35A of Listing Agreement.","05-Aug-2013 17:52:00","2013-08-05 17:52:00","-","-","https://nsearchives.nseindia.com/corporate/Votingresults35A_08052013175202_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Annual General Meeting Updates","Divi's Laboratories Limited has informed the Exchange regarding a Outcome of Annual General Meeting of the Company held on August 05, 2013.","05-Aug-2013 14:16:00","2013-08-05 14:16:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_OUTCOMEAGM_05082013_08052013141602_2.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange vide letter dated August 03, 2013 regarding a press release, titled ""Divi's Labs earns a PAT of Rs.175 crores for Q1 of FY14"".","05-Aug-2013 12:44:00","2013-08-05 12:44:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_Pr_05082013_08052013124401_2.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30,2013.","05-Aug-2013 10:05:55","2013-08-05 10:05:55","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30JUN2013_S_Q1.zip"
"DIVISLAB","Divi's Laboratories Limited","Discl. under SEBI Insider Trading and Takeover Regulation","Divi's Laboratories Limited has submitted to the Exchange vide letter dated July 16, 2013 a copy of disclosure pursuant to Regulation 13(3) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992","16-Jul-2013 16:44:00","2013-07-16 16:44:00","-","-","https://nsearchives.nseindia.com/corporate/DisclosureFormC_07162013164402_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Discl. under SEBI Insider Trading and Takeover Regulation","Reliance Capital Asset Management Limited has submitted to the Exchange vide letter dated July 15, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(3) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992","16-Jul-2013 13:16:00","2013-07-16 13:16:00","-","-","https://nsearchives.nseindia.com/corporate/Divislaboratories_07162013131601_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Date of payment of dividend","Divi's Laboratories Limited has informed the Exchange that the dividend, when declared at the Annual General Meeting, will he credited / dispatched on August 19, 2013.","01-Jul-2013 14:48:00","2013-07-01 14:48:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi's Laboratories Limited has informed the Exchange that the Share Transfer Books of the Company will remain close from July 29, 2013 to August 2, 2013(both days inclusive) for the purpose of the Annual General Meeting of the Company scheduled to be held on August 05, 2013 and payment of dividend, if declared at the ensuing Annual General Meeting. ","01-Jul-2013 14:40:00","2013-07-01 14:40:00","-","-","https://nsearchives.nseindia.com/corporate/AGMNotice_07012013144001_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 20, 2013 has recommended a dividend of 750% i.e. Rs. 15/- per equity share of Rs. 2/- face value for the year ended March 31, 2013.","21-May-2013 09:48:00","2013-05-21 09:48:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2013.","21-May-2013 09:41:55","2013-05-21 09:41:55","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31MAR2013_B_Q4A.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated May 20, 2013, titled ""Divi's Labs earns a consolidated Total Income of Rs.2145 crores in FY13"".","21-May-2013 09:40:00","2013-05-21 09:40:00","-","-","https://nsearchives.nseindia.com/corporate/DIVILAB_pr_21052013_05212013094001_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Resignation of Director","Divi's Laboratories Limited has informed the Exchange that Prof. C. Ayyanna, Independent Director of the Company has resigned from the Board due to personal reasons and other pre-occupations. The Board has accepted his resignation and appreciated his contribution to the Company.","20-May-2013 19:04:00","2013-05-20 19:04:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi's Laboratories Limited has informed the Exchange regarding a press release dated February 02, 2012, titled ""Divi's Labs earns an Income of Rs.534 crores in Q3 of FY13"".","04-Feb-2013 12:28:00","2013-02-04 12:28:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_pr_04012013_02042013122801_1.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2012 with Limited Review Report.","04-Feb-2013 09:23:47","2013-02-04 09:23:47","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31DEC2012_S_Q3.zip"
"DIVISLAB","Divi's Laboratories Limited","Change in Director(s)","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 03, 2012, has appointed Sri. Ranga Rao Ravipati as Additional Director (Independent and Non-Executive) on the Board of the Company w.e.f. November 03, 2012. Further, the Company has informed the Exchange that, Sri. G. Venkata Rao, Independent Director of the Company has resigned from the Board due to personal reasons and other pre-occupations. The Board has accepted his resignation and appreciated his contribution to the Company. ","05-Nov-2012 10:03:00","2012-11-05 10:03:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release dated November 03, 2012, titled ""Divi's Labs earns an Income of Rs.474 crores in Q2 of FY13"".","05-Nov-2012 08:44:00","2012-11-05 08:44:00","-","-","https://nsearchives.nseindia.com/corporate/DIVIO_PR_05112012.ZIP"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended September 30,2012.","03-Nov-2012 17:53:34","2012-11-03 17:53:34","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30SEP2012_S_Q2.zip"
"DIVISLAB","Divi's Laboratories Limited","News Clarification","Divi'S Laboratories Limited has informed the Exchange vide letter dated August 28, 2012, regarding ""Clarification on rumours about financial irregularity"".","28-Aug-2012 13:29:00","2012-08-28 13:29:00","-","-","https://nsearchives.nseindia.com/corporate/DivisLab_clarif_28082012.zip"
"DIVISLAB","Divi's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Divi'S Laboratories Limited has informed the Exchange regarding details of Voting Results of Annual General Meeting of the Company held on August 06, 2012 pursuant to clause 35A of Listing Agreement.","06-Aug-2012 18:25:00","2012-08-06 18:25:00","-","-","https://nsearchives.nseindia.com/corporate/DIVIS_35A_06082012.zip"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Annual General Meeting","Divi'S Laboratories Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the Company held on August 06, 2012.","06-Aug-2012 13:16:00","2012-08-06 13:16:00","-","-","https://nsearchives.nseindia.com/corporate/DIVI_OAGM_06082012.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding the press release dated August 04, 2012 titled ""Divi's Labs earns a PBT of Rs.214 crores for Q1 of FY13"".","06-Aug-2012 10:19:00","2012-08-06 10:19:00","-","-","https://nsearchives.nseindia.com/corporate/DIVIS_pr_06082012.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30, 2012.","06-Aug-2012 10:14:53","2012-08-06 10:14:53","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30JUN2012_S_Q1.zip"
"DIVISLAB","Divi's Laboratories Limited","Clarification","Divi'S Laboratories Limited has informed the Exchange vide letter dated July 13, 2012, regarding ""Clarification on order/closure notice of AP Pollution Control Board"".","13-Jul-2012 10:35:00","2012-07-13 10:35:00","-","-","https://nsearchives.nseindia.com/corporate/DiviLab_clarification_13072012.zip"
"DIVISLAB","Divi's Laboratories Limited","Date of payment of dividend","Divi'S Laboratories Limited had informed the Exchange that dividend will be credited / dispatched on August 20, 2012. The Company has now informed the Exchange that the dividend payment date will be considered as August 21, 2012.","02-Jul-2012 14:58:00","2012-07-02 14:58:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","AGM / Book Closure","Divi'S Laboratories Limited has informed the Exchange that the Share Transfer Books of the Company will remain closed from July 30, 2012 to August 03, 2012 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on August 06, 2012 and payment of Dividend, if declared at the ensuing Annual General Meeting. Further dividend will be credited / dispatched on August 20, 2012.","02-Jul-2012 10:07:00","2012-07-02 10:07:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2012.","12-May-2012 17:02:29","2012-05-12 17:02:29","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31MAR2012_B_Q4A.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a Press Release dated May 12, 2012, titled ""Divi's Labs Q4 Cons. Total Income grows by 50% to Rs.722 crores"".","12-May-2012 16:23:00","2012-05-12 16:23:00","-","-","https://nsearchives.nseindia.com/corporate/Divi_Pr_12052012.zip"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 12, 2012, has recommended a dividend of 650% i.e. Rs. 13/- per equity share of Rs. 2/- face value for the year ended March 31, 2012.","12-May-2012 16:22:00","2012-05-12 16:22:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Divi'S Laboratories Limited has informed the Exchange, vide letter dated April 20, 2012 regarding ""Clause 35A - Declaration of Postal Ballot Results"".","20-Apr-2012 19:56:00","2012-04-20 19:56:00","-","-","https://nsearchives.nseindia.com/corporate/divis_rpb_20042012.zip"
"DIVISLAB","Divi's Laboratories Limited","Publish Audited Results","Divi'S Laboratories Limited has informed the Exchange that the Audited Financial Results of the Company for the entire financial year 2011-2012 shall be considered and published by the company within the stipulated time period of sixty days from the end of the financial year i.e., on or before May 30, 2012. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on March 31, 2012.","19-Apr-2012 17:10:00","2012-04-19 17:10:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Notice of Postal Ballot","Divi'S Laboratories Limited has submitted to the Exchange a copy of notice pursuant to Section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2011 in respect of the Resolution to be passed through Postal Ballot : (1) Re-appointment and revision in remuneration of Mr. Madhusudana Rao Divi as Director - Projects of the Company, (2) Re-appointment and revision in remuneration of Mr. Kiran S. Divi as Director & President- Operations of the Company, (3) Enhancement of remuneration of Dr. Murali K. Divi, Chairman & Managing Director of the Company, (4)Enhancement of remuneration of Mr. N. V. Ramana, Executive Director of the Company.","19-Mar-2012 18:20:00","2012-03-19 18:20:00","-","-","https://nsearchives.nseindia.com/corporate/Divis_NPB_190312.zip"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Securities","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors on March 05, 2012 made the allotment of 31180 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132734290 equity shares from 132703110 equity shares of face value Rs. 2/- each.","06-Mar-2012 10:55:00","2012-03-06 10:55:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2011.","30-Jan-2012 08:37:16","2012-01-30 08:37:16","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31DEC2011_S_Q3.zip"
"DIVISLAB","Divi's Laboratories Limited","Resignation of Director","Divi'S Laboratories Limited has informed the Exchange that Dr. P. Gundu Rao, Non-Executive Director of the Company has resigned from the Board as he relocated to the USA to spend time with his family. The Board has accepted his resignation and appreciated his constribution to the Company.","30-Jan-2012 08:24:00","2012-01-30 08:24:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited  has informed the Exchange regarding a Press Release dated January 28, 2012, titled ""Divi's Labs earns an Income of Rs.417 crores in Q3 of FY11-12"".","30-Jan-2012 08:07:00","2012-01-30 08:07:00","-","-","https://nsearchives.nseindia.com/corporate/Divis_pr_30012012.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a Press Release dated November 01, 2011, titled ""Divi's Labs earns an Income of Rs.366 crores in Q2 of FY11"".","01-Nov-2011 18:25:00","2011-11-01 18:25:00","-","-","https://nsearchives.nseindia.com/corporate/DiviLab_pr_01112011.zip"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Securities","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors in its meeting held on November 01, 2011 made the allotment of 26560 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the Company will get increased to 132703110 equity shares from 132676550 equity shares of face value Rs. 2/- each.","01-Nov-2011 18:11:00","2011-11-01 18:11:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.","01-Nov-2011 17:37:25","2011-11-01 17:37:25","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30SEP2011_S_Q2H.zip"
"DIVISLAB","Divi's Laboratories Limited","Reg.3(3) of SEBI (Substantial Acq of shares &Takeovers),1997","Kiran S Divi has submitted to the Exchange a copy of Disclosure under Regulation 3(3) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997.","28-Sep-2011 18:15:00","2011-09-28 18:15:00","-","-","https://nsearchives.nseindia.com/corporate/Divilab_Kiran_28092011.zip"
"DIVISLAB","Divi's Laboratories Limited","Reg.3(3) of SEBI (Substantial Acq of shares &Takeovers),1997","Nilima Motparti has submitted to the Exchange a copy of Disclosure under Regulation 3(3) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997.","28-Sep-2011 18:14:00","2011-09-28 18:14:00","-","-","https://nsearchives.nseindia.com/corporate/Divilabs_Nilima_28092011.zip"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Annual General Meeting","Divi'S Laboratories Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the members of the Company held on August 08, 2011.","08-Aug-2011 13:16:00","2011-08-08 13:16:00","-","-","https://nsearchives.nseindia.com/corporate/DIVIS_outcomeofagm_08082011.zip"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange  regarding a Press Release dated August 06, 2011 titled ""Divi's Labs earns a PBT of Rs. 130 crores for Q1 of FY12"".","06-Aug-2011 18:04:00","2011-08-06 18:04:00","-","-","https://nsearchives.nseindia.com/corporate/DIVILAB_PR_06082011.zip"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Securities","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors in its meeting held on August 06, 2011 made the allotment of 26520 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the Company will get increased to 132676550 equity shares from 132650030 equity shares of face value Rs. 2/- each.","06-Aug-2011 17:57:00","2011-08-06 17:57:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2011.","06-Aug-2011 17:13:16","2011-08-06 17:13:16","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30JUN2011_S_Q1.zip"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi'S Laboratories Limited has informed the Exchange that it has had an inspection by the US-FDA, with no major observations, for its Unit-I at Vill. Lingojigudem, Choutuppal Mandal near Hyderabad during July, 2011. The audit concluded with minor observations primarily about additional records for further improvement of existing records. The purpose of this inspection was for product pre-approval and general cGMP (Current Good Manufacturing Practices).","03-Aug-2011 09:56:00","2011-08-03 09:56:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","AGM / Book Closure","Divi'S Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from June 18, 2011 to June 24, 2011 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on August 08, 2011 and payment of Dividend, if declared at the ensuing Annual General Meeting.","27-May-2011 14:47:00","2011-05-27 14:47:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Securities","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors in its meeting held on May 20, 2011 made the allotment of 54920 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132650030 equity shares from 132595110 equity shares of face value Rs. 2/- each.","23-May-2011 17:47:00","2011-05-23 17:47:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi'S Laboratories Limited has informed the Exchange that Dr.P.Gundu Rao, Director (R&D) of the Company has resigned as whole-time Director of the Company effective June 01, 2011. Dr.Gundu Rao will, however, continue as a Non-Executive Director of the Company.","23-May-2011 17:46:00","2011-05-23 17:46:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2011.","23-May-2011 09:50:30","2011-05-23 09:50:30","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31MAR2011_B_Q4A.zip"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Year ended, 31-MAR-2011 (Standalone)","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 130544 lacs for year ending on 31-MAR-2011 against Rs. 92928 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 43557 lacs for the year ending on 31-MAR-2011 against Rs. 34420 lacs for the year ending on 31-MAR-2010.","23-May-2011 09:03:00","2011-05-23 09:03:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Year ended, 31-MAR-2011 (Consolidated)","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 130711 lacs for year ending on 31-MAR-2011 against Rs. 94161 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 42927 lacs for the year ending on 31-MAR-2011 against Rs. 34034 lacs for the year ending on 31-MAR-2010.","23-May-2011 09:02:00","2011-05-23 09:02:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release dated May 20, 2011, titled ""Divi's Labs PAT for Q4 grew by 36% to Rs.175 Crores"".","23-May-2011 08:56:00","2011-05-23 08:56:00","-","-","https://nsearchives.nseindia.com/corporate/DIVI_PR_23052011.zip"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors at its meeting held on May 20, 2011 has recommended a dividend of 500% i.e. Rs. 10/- per equity share of Rs. 2/- face value for the year ended March 31, 2011.","23-May-2011 08:54:00","2011-05-23 08:54:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Publish Audited Results","Divi'S Laboratories Limited has informed the Exchange that the Audited Financial Results of the Company for the entire financial year 2010-2011 shall be considered and published by the company within the stipulated time period of sixty days from the end of the financial year i.e., on or before May 30, 2011. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on March 31, 2011.","25-Apr-2011 17:18:00","2011-04-25 17:18:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","News Clarification","Divi'S Laboratories Limited has informed the Exchange regarding a webcast in News channel on April 01, 2011 reporting that  ""Divi's Labs is looking to acquire US Biotech companies"". The Company has clarified that there are no plans or discussions or negotiations to acquire any biotech Company or of any fund raising.","04-Apr-2011 10:00:00","2011-04-04 10:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Securities","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors in its meeting held on February 4, 2011 made the allotment of 29690 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132595110 equity shares from 132565420 equity shares of face value Rs. 2/- each.","04-Feb-2011 11:57:00","2011-02-04 11:57:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release dated February 04, 2011, titled ""Divi's Labs earns an Income of Rs.313 crores for Q3 of FY11"".","04-Feb-2011 11:52:00","2011-02-04 11:52:00","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_pr_04022011.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended December 31,2010.","04-Feb-2011 11:50:26","2011-02-04 11:50:26","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_31DEC2010_B_Q3.zip"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 31-DEC-2010 (Consolidated)","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 30969 lacs for quarter ending on 31-DEC-2010 against Rs. 19631 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 9842 lacs for the quarter ending on 31-DEC-2010 against Rs. 6784 lacs for the quarter ending on 31-DEC-2009.","04-Feb-2011 11:49:00","2011-02-04 11:49:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 31-DEC-2010 (Standalone)","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 31005 lacs for quarter ending on 31-DEC-2010 against Rs. 18990 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 10157 lacs for the quarter ending on 31-DEC-2010 against Rs. 6879 lacs for the quarter ending on 31-DEC-2009.","04-Feb-2011 11:48:00","2011-02-04 11:48:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Securities","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors in its meeting held on November 09, 2010 made the allotment of 34180 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132565420 equity shares from 132531240 equity shares of face value Rs.2/- each.","09-Nov-2010 19:22:00","2010-11-09 19:22:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release dated November 09, 2010 , titled ""Divi's Labs earns an Income of Rs. 524 crores in H1 of FY10""","09-Nov-2010 19:17:00","2010-11-09 19:17:00","-","-","https://nsearchives.nseindia.com/corporate/DIVI_PR_09112010.zip"
"DIVISLAB","Divi's Laboratories Limited","Financial Result Updates","Divi's Laboratories Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended September 30,2010.","09-Nov-2010 18:20:32","2010-11-09 18:20:32","-","-","https://nsearchives.nseindia.com/corporate/DIVISLAB_30SEP2010_B_Q2H.zip"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 30-SEP-2010 (Consolidated)","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 25531 lacs for quarter ending on 30-SEP-2010 against Rs. 22534 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 7193 lacs for the quarter ending on 30-SEP-2010 against Rs. 8479 lacs for the quarter ending on 30-SEP-2009.","09-Nov-2010 18:10:00","2010-11-09 18:10:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 30-SEP-2010 (Standalone)","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 25330 lacs for quarter ending on 30-SEP-2010 against Rs. 22287 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 7296 lacs for the quarter ending on 30-SEP-2010 against Rs. 8644 lacs for the quarter ending on 30-SEP-2009.","09-Nov-2010 18:09:00","2010-11-09 18:09:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Annual General Meeting","Divi'S Laboratories Limited has informed the Exchange regarding the outcome of the Annual General Meeting of the Company held on August 13, 2010.","13-Aug-2010 13:48:00","2010-08-13 13:48:00","-","-","https://nsearchives.nseindia.com/corporate/DivisLab_OAM_13082010.zip"
"DIVISLAB","Divi's Laboratories Limited","Outcome of meeting","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors in its meeting held on August 12, 2010 made the allotment of 387095 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the Company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132531240 equity shares from 132144145 equity shares of face value Rs.2/- each.","12-Aug-2010 20:09:00","2010-08-12 20:09:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding the press release dated August 12, 2010 titled""Divi's Labs earns an Income of Rs.265 crores in Q1"".","12-Aug-2010 18:32:00","2010-08-12 18:32:00","-","-","https://nsearchives.nseindia.com/corporate/DIVIS_PR_12082010.ZIP"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 30-JUN-2010 (Consolidated)","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 26350 lacs for quarter ending on 30-JUN-2010 against Rs. 20583 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 8373 lacs for the quarter ending on 30-JUN-2010 against Rs. 429 lacs for the quarter ending on 30-JUN-2009.","12-Aug-2010 18:05:00","2010-08-12 18:05:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 30-JUN-2010 (Standalone)","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 26254 lacs for quarter ending on 30-JUN-2010 against Rs. 20277 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 8629 lacs for the quarter ending on 30-JUN-2010 against Rs. 492 lacs for the quarter ending on 30-JUN-2009.","12-Aug-2010 18:04:00","2010-08-12 18:04:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi'S Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from July 06, 2010 to July 10, 2010 (Both days inclusive) for the purpose of Annual General Meeting of the Company to be held on August 13, 2010 and payment of Dividend, if declared at ensuing Annual General Meeting.","23-Jun-2010 12:49:00","2010-06-23 12:49:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors at its meeting held on May 22, 2010 has recommended a dividend of 300% i.e. Rs. 6/- per equity share of Rs. 2/- face value for the year ended March 31, 2010.","24-May-2010 09:05:00","2010-05-24 09:05:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release dated  May 22, 2010 , titled "" Divi's Labs earns a PAT of Rs. 129 crores for Q4"".","24-May-2010 09:01:00","2010-05-24 09:01:00","-","-","https://nsearchives.nseindia.com/corporate/Divis_PR1_24052010.zip"
"DIVISLAB","Divi's Laboratories Limited","Publish Audited Results","Divi'S Laboratories Limited has informed the Exchange that: ""The Audited Financial Results of the Company for the entire financial year 2009-2010 shall be considered and published by the company within the stipulated time period of sixty days from the end of the financial year i.e., on or before 30th May, 2010. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on 31st March 2010 "".","26-Apr-2010 15:01:00","2010-04-26 15:01:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi'S Laboratories Limited has informed the Exchange that ""The Company has received letter of approval from the Development Commissioner, Visakhapatnam Special Economic Zone, for setting up and development of a new manufacturing Unit in Our Special Economic Zone for pharma ingredients at Vill., Chippada, Bheemunipatnam Mandal, Visakhapatnam Dist. The Project cost is estimated at Rs.200 crores"".","26-Apr-2010 14:59:00","2010-04-26 14:59:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Equity Shares","Divi'S Laboratories Limited has informed the Exchange that ""Compensation Committee of Board of Directors in its meeting held on 25th March 2010 made the allotment of 1166635 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 132144145 equity shares from 130977510 equity shares of face value Rs.2/- each"".","25-Mar-2010 13:34:00","2010-03-25 13:34:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Equity Shares","Divi'S Laboratories Limited has informed the Exchange that ""Compensation Committee of Board of Directors in its meeting held on 29th January 2010 made the allotment of 232965 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 130977510 equity shares from 130744545 equity shares of face value Rs.2/- each"".","29-Jan-2010 18:44:00","2010-01-29 18:44:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release dated January 29, 2010, titled ""Divi's Labs earns an Income of Rs.649 crores for 9M of FY10"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DIVISLAB_pr_29012010.ZIP target=NEW> For more details click here.</a>","29-Jan-2010 18:12:00","2010-01-29 18:12:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 31-DEC-2009 (Consolidated)","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 19631 lacs for quarter ending on 31-DEC-2009 against Rs. 26475 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 6784 lacs for the quarter ending on 31-DEC-2009 against Rs. 7953 lacs for the quarter ending on 31-DEC-2008.","29-Jan-2010 17:49:00","2010-01-29 17:49:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 31-DEC-2009 (Standalone)","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 18990 lacs for quarter ending on 31-DEC-2009 against Rs. 26742 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 6879 lacs for the quarter ending on 31-DEC-2009 against Rs. 8242 lacs for the quarter ending on 31-DEC-2008.","29-Jan-2010 17:47:00","2010-01-29 17:47:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results of Postal Ballot","Divi'S Laboratories Limited has submitted to the Exchange a copy of the report issued by Mr. V Bhasakara Rao, Company Secretary in Practice, Scrutinizer for the Postal ballot conducted in pursuance of Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution through Postal Ballot) Rules 2001, in respect of: (1) Re-appointment of Dr. Murali K Divi as Chairman & Managing Director of the Company. (2) Re-appointment of Mr. N V Ramana as Executive Director of the Company. Basing on the report submitted by the Scrutinizer, Dr. P Gundu Rao, Director (R&D) has declared that the resolutions are passed with requisite majority. A copy of the scrutinizer's report shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/divis_RPB_27112009.zip target=NEW> For more details click here.</a>","27-Nov-2009 12:37:00","2009-11-27 12:37:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Equity Shares","Divi'S Laboratories Limited has informed the Exchange that ""Compensation Committee of Board of Directors in its meeting held on 30th October 2009 made the allotment of 187550 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 130744545 equity shares from 130556995 equity shares of face value Rs.2/- each"".","30-Oct-2009 21:14:00","2009-10-30 21:14:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Note","Divi'S Laboratories Limited has informed the Exchange regarding a press note dated October 30, 2009, titled ""Divi's Labs earns an Income of Rs.445 crores in H1 of FY10"". A copy of the press note shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divi_PN_30102009.zip target=NEW> For more details click here.</a>","30-Oct-2009 19:10:00","2009-10-30 19:10:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Half Year ended, 30-SEP-2009 (Consolidated)","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 43117 lacs for half year ending on 30-SEP-2009 against Rs. 59405 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 8908 lacs for the half year ending on 30-SEP-2009 against Rs. 22972 lacs for the half year ending on 30-SEP-2008.","30-Oct-2009 18:19:00","2009-10-30 18:19:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Half Year ended, 30-SEP-2009 (Standalone)","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 42564 lacs for half year ending on 30-SEP-2009 against Rs. 59729 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 9136 lacs for the half year ending on 30-SEP-2009 against Rs. 23416 lacs for the half year ending on 30-SEP-2008.","30-Oct-2009 18:18:00","2009-10-30 18:18:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 30-SEP-2009 (Consolidated)","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 22534 lacs for quarter ending on 30-SEP-2009 against Rs. 33047 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 8479 lacs for the quarter ending on 30-SEP-2009 against Rs. 13539 lacs for the quarter ending on 30-SEP-2008.","30-Oct-2009 18:16:00","2009-10-30 18:16:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results Update, Quarter ended, 30-SEP-2009 (Standalone)","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 22287 lacs for quarter ending on 30-SEP-2009 against Rs. 33122 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 8644 lacs for the quarter ending on 30-SEP-2009 against Rs. 13768 lacs for the quarter ending on 30-SEP-2008.","30-Oct-2009 18:15:00","2009-10-30 18:15:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Notice of Postal Ballot","Divi'S Laboratories Limited has informed the Exchange that pursuant to Section 192A (2) of the Companies Act, 1956, read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001, that Resolution are proposed to be passed by Postal Ballot for the following matters: 1) Re-appointment of Dr Murali K Divi as Chairman & Managing Director of the Company. 2) Re-appointment of Mr.N V Ramana as Executive Director of the Company.  A copy of the notice of postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DIVI_notice_24102009.zip target=NEW> For more details click here.</a>","24-Oct-2009 15:45:00","2009-10-24 15:45:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Equity Shares","Divi'S Laboratories Limited has informed the Exchange that ""Compensation Committee of Board of Directors in its meeting held on 17th August 2009 made the allotment of 861045 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the Company will get increased to 130556995 equity shares from 129695950 equity shares of face value Rs.2/- each"".","17-Aug-2009 18:36:00","2009-08-17 18:36:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Outcome of AGM","Divi'S Laboratories Limited has informed the Exchange that the members of the Company passed the following resolutions at the Annual General Meeting held on August 17, 2009: 1) Adopted the audited accounts for the year ended March 31, 2009. 2) Approval for payment of dividend at Rs.6 for each equity share. 3) Re-appointment of Mr. S Vasudev, as Director liable to retire by rotation. 4) Re-appointment of Dr G Suresh Kumar, as Director liable to retire by rotation. 5) Re-appointment of Mr. Kiran S Divi, as Director liable to retire by rotation. 6) Re-appointment of M/s. P.V.R.K. Nageswara Rao & Co., Chartered Accountants, as Statutory Auditors of the Company to hold office till the conclusion of next AGM.","17-Aug-2009 13:28:00","2009-08-17 13:28:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Clarification","Divi'S Laboratories Limited has informed the Exchange that ""Based on repeated enquiries from shareholders if any shares were purchased by the promoters / directors on 05-August-2009, we wish to clarify that the 'Disclosure' by the Directors of the Company is only for the allotment of Bonus Shares but not purchase of shares in the market"".","07-Aug-2009 12:20:00","2009-08-07 12:20:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that as per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the (as per list attached), who are Directors, have intimated the company on August 05, 2009, stating that their holdings have changed consequent to the allotment of equity shares as bonus shares in the proportion of one equity share for every one equity share held by them in the company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divis_reg_05082009.zip target=NEW> For more details click here.</a>","05-Aug-2009 13:01:00","2009-08-05 13:01:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Equity Shares","Divi'S Laboratories Limited has informed the Exchange that Allotment Committee of Board of Directors in its meeting held on August 02, 2009 made the allotment of 64847975 equity shares of Rs.2/- each as Bonus Shares to the shareholders of the Company in the ratio of 1:1. Consequently, the paid-up equity share capital of the Company has increased to 129695950 equity shares from 64847975 equity shares of face value Rs.2/- each.","04-Aug-2009 13:05:00","2009-08-04 13:05:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release dated July 31, 2009  titled ""Divi's Labs earns an Income of Rs. 218 crores in Q1"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/divi_PR_31072009.zip target=NEW> For more details click here.</a>","31-Jul-2009 19:06:00","2009-07-31 19:06:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Quarter ended, 30-JUN-2009","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 20277 lacs for quarter ending on 30-JUN-2009 against Rs. 26607 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 492 lacs for the quarter ending on 30-JUN-2009 against Rs. 9648 lacs for the quarter ending on 30-JUN-2008.","31-Jul-2009 18:44:00","2009-07-31 18:44:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-JUN-2009","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 20583 lacs for quarter ending on 30-JUN-2009 against Rs. 26358 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 429 lacs for the quarter ending on 30-JUN-2009 against Rs. 9433 lacs for the quarter ending on 30-JUN-2008.","31-Jul-2009 18:43:00","2009-07-31 18:43:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Record Date","Divi'S Laboratories Limited has informed the Exchange that August 01, 2009 has been fixed as the Record Date for determining the eligibility of shareholders entitled to receive the Bonus Shares.","22-Jul-2009 19:06:00","2009-07-22 19:06:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results of Postal Ballot","Divi's Laboratories Limited has submitted to the Exchange vide its letter dated July 22, 2009 a copy of the report issued by Mr. V. Bhasakara Rao, Company Secretary in Practice, Scrutinizer for the Postal Ballot conducted in pursuance of Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution through Postal Ballot) Rules 2001, in respect of : 1) Increase in Authorised Capital and alteration of Authorised capital in the Memorandum of Association of the company. 2) Alteration of Authorised Capital in the Articles of Association of the company. 3) Issue of bonus shares. Basing on the report submitted by the Scrutinizer, Dr. P Gundu Rao, Director (R&D) has declared on this day that the resolutions are passed with requisite majority. The Stock Exchange is hereby informed that the members of the company have approved the issue of bonus shares in the ratio of one share for every share held. A copy of the same shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/divi_resultofpostalballot_22072009.zip target=NEW> For more details click here.</a>","22-Jul-2009 18:21:00","2009-07-22 18:21:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Notice of Postal Ballot","Divi's Laboratories Limited has informed the Exchange that Notice pursuant to Section 192A(2) of the Companies Act, 1956, read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001, that Resolution are proposed to be passed by Postal Ballot for the following matters: (1) Ordinary Resolution to accord the consent of the Company to increase Authorised Capital and alteration of Authorised Capital in the Memorandum of Association of the Company.(2) Special Resolution to accord the consent of the Company for Alteration of Authorised Capital in Articles of Association of the Company. (3) Ordinary Resolution to accord the consent of the Company to Issue Bonus Shares. A copy of the notice of the postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/divi_noticePB_22062009.zip target=NEW> For more details click here.</a>","22-Jun-2009 19:30:00","2009-06-22 19:30:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi'S Laboratories Limited has informed the Exchange that the Share Transfer Books of the Company will remain closed from June 17, 2009 to June 20, 2009 (both days inclusive) for the purpose of the Annual General Meeting of the Company scheduled to be held on August 17, 2009 and payment of dividend, if declared at the ensuing Annual General Meeting.","08-Jun-2009 10:04:00","2009-06-08 10:04:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange vide its letter dated June 06, 2009 regarding the press release, titled ""Divi's Labs earns a PAT of Rs.417 for the year 2008-09 And declares 1:1 bonus"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/divislab_pr_08062009.zip target=NEW> For more details click here.</a>","08-Jun-2009 09:26:00","2009-06-08 09:26:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors at its meeting held on June 06, 2009, has recommended a dividend of Rs. 6/- per equity share of Rs. 2 each i.e., 300% for the year ended March 31, 2009.","08-Jun-2009 09:17:00","2009-06-08 09:17:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Bonus","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors at its meeting held on June 06, 2009 has recommended issue of bonus shares in the ratio of one share for every share held, subject to approval of members.","08-Jun-2009 09:13:00","2009-06-08 09:13:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results of Postal Ballot","Divi'S Laboratories Limited has informed the Exchange about the report issued by Mr. V Bhasakara Rao, Company Secretary in Practice, Scrutinizer for the Postal Ballot conducted in pursuance of Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution through Postal Ballot) Rules 2001, in respect of: 1) Re-appointment of Mr. Madhusudana Rao Divi as Director (Projects) of the Company. 2) Re-appointment of Mr. Kiran S Divi as Director (Business Development) of the Company. 3) Appointment of a relative of the director to an office or place of profit u/s 314(1B) of the Companies Act, 1956. Basing on the report submitted by the Scrutinizer, Dr. P Gundu Rao, Director (R&D) has declared on May 20, 2009 that the resolution are passed with requisite majority. The details of the results of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divi_ResultofPB_21052009.zip target=NEW> For more details click here.</a>","21-May-2009 10:06:00","2009-05-21 10:06:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot","Divi'S Laboratories Limited has informed the Exchange that Board of Directors in their meeting held on April 14, 2009 has decided to seek shareholders approval by postal ballot for: 1) Re-appointment of Mr Madhusudana Rao Divi as Director (Projects) of the Company. 2) Re-appointment of Mr Kiran S Divi as Director (Business Development) of the Company. 3) Appointment of a relative of the director to an office or place of profit u/s 314(1B) of the Companies Act, 1956. Accordingly notice pursuant to section 192(A) of the Companies Act 1956 along with explanatory statement under section 173(2) of the Companies Act 1956 is being sent to shareholders for passing of resolutions. Board has appointed Mr. V. Bhaskara Rao, Practicing Company Secretary, as the scrutinizer for conducting the Postal Ballot process in a fair and transparent manner. The duly completed Postal Ballot form should reach the Scrutinizer not later than the close of working hours on May 18, 2009 and the result of the Postal Ballot will be announced by a Director on May 20, 2009. A copy of the Notice of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divis_Notice_20042009.zip target=NEW> For more details click here.</a>","20-Apr-2009 18:27:00","2009-04-20 18:27:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Equity Shares","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors in its meeting held on April 14, 2009 made the allotment of 89950 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64847975 equity shares from 64758025 equity shares of face value Rs.2/- each.","15-Apr-2009 19:13:00","2009-04-15 19:13:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Publish Audited Results","Divi's Laboratories Limited has informed the Exchange that ""The Audited Financial Results of the Company for the entire financial year 2008-2009 shall be considered and published by the company within a period of three months from the end of the financial year, i.e. on or before 30th June, 2009. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on 31st March, 2009"".","15-Apr-2009 15:19:00","2009-04-15 15:19:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi'S Laboratories Limited has submitted to the Exchange a copy of the Abstract of terms being issued to the members of the company pursuant to Section 302 of the Companies Act,1956 regarding re-appointment of Whole-time Directors of the company. The details of the same shall be available on the NSE website http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DiviLab_Abs_30032009.zip target=NEW> For more details click here.</a>","30-Mar-2009 20:00:00","2009-03-30 20:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Clarification","Divi'S Laboratories Limited has informed the Exchange with reference to the mails and messages circulating regarding an alleged pledging of promoter's shareholding in the company with India Bulls or some institution that: ""We hereby clarify and confirm that there is no pledge, whatsoever, of any shares held by the promoter in Divi's Laboratories Limited. Infact, the promoter does not have any loans from any bank or institution.""","28-Jan-2009 13:16:00","2009-01-28 13:16:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding the press release, dated January 24, 2009 titled ""Divi's Labs PAT for 9 months grows by 21% to Rs.309 crores"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).   <a href=/content/corporate/Divis_PR_240120089.zip target=NEW> For more details click here.</a>","24-Jan-2009 15:27:00","2009-01-24 15:27:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Equity Shares","Divi'S Laboratories Limited has informed the Exchange that the Compensation Committee of Board of Directors in its meeting held on January 24, 2009 made the allotment of 9500 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64758025 equity shares from 64748525  equity shares of face value Rs. 2/- each.","24-Jan-2009 15:19:00","2009-01-24 15:19:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Quarter ended, 31-DEC-2008","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 26742 lacs for quarter ending on 31-DEC-2008 against Rs. 33122 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 8242 lacs for the quarter ending on 31-DEC-2008 against Rs. 13768 lacs for the quarter ending on 30-SEP-2008.","24-Jan-2009 12:44:00","2009-01-24 12:44:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Quarter ended, 31-DEC-2008","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 26475 lacs for quarter ending on 31-DEC-2008 against Rs. 28413 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 7953 lacs for the quarter ending on 31-DEC-2008 against Rs. 9906 lacs for the quarter ending on 31-DEC-2007.","24-Jan-2009 12:42:00","2009-01-24 12:42:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Divi'S Laboratories Limited has submitted to the Exchange the details as per the SEBI (Prohibition of Insider Trading) Regulation, 2002, regarding the insider, who is Director, has intimated the company on October 31, 2008, stating that his holding has changed consequent to the allotment of equity shares under Employee Stock Option Scheme 2006 of the company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divi_Reg_03112008.zip target=NEW> For more details click here.</a>","03-Nov-2008 12:39:00","2008-11-03 12:39:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Equity Shares","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors in its meeting held on October 29, 2008 made the allotment of 24400 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64748525 equity shares from 64724125 equity shares of face value Rs.2/- each.","30-Oct-2008 18:41:00","2008-10-30 18:41:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Half Yearly ended, 30-SEP-2008","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 59405 lacs for half year ending on 30-SEP-2008 against Rs. 47056 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 22972 lacs for the half year ending on 30-SEP-2008 against Rs. 15586 lacs for the half year ending on 30-SEP-2007.","29-Oct-2008 17:20:00","2008-10-29 17:20:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Half Yearly ended, 30-SEP-2008","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 59729 lacs for half year ending on 30-SEP-2008 against Rs. 47058 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 23416 lacs for the half year ending on 30-SEP-2008 against Rs. 15853 lacs for the half year ending on 30-SEP-2007.","29-Oct-2008 17:19:00","2008-10-29 17:19:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-SEP-2008","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 33047 lacs for quarter ending on 30-SEP-2008 against Rs. 24384 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 13539 lacs for the quarter ending on 30-SEP-2008 against Rs. 9097 lacs for the quarter ending on 30-SEP-2007.","29-Oct-2008 17:19:00","2008-10-29 17:19:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Quarter ended, 30-SEP-2008","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 33122 lacs for quarter ending on 30-SEP-2008 against Rs. 24251 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 13768 lacs for the quarter ending on 30-SEP-2008 against Rs. 9125 lacs for the quarter ending on 30-SEP-2007.","29-Oct-2008 17:18:00","2008-10-29 17:18:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding the press release, titled ""Divi's Labs PAT for Q2 grows by 49% to Rs.135 crores"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).   <a href=/content/corporate/Divi_PR_29102008.zip target=NEW> For more details click here.</a>","29-Oct-2008 17:11:00","2008-10-29 17:11:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Divi'S Laboratories Limited has submitted to the Exchange details as per the SEBI (Prohibition of Insider Trading) Regulation, 2002.The insider who is Director, have intimated the company on September 04, 2008, stating that he has sold the equity shares held by him in the company. Name of Director: Dr. P Gundu Rao; Sell Quantity: 3000 equity shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divi_Update_05092008.zip target=NEW> For more details click here.</a>","05-Sep-2008 19:02:00","2008-09-05 19:02:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Outcome of AGM","Divi'S Laboratories Limited has informed the Exchange regarding the outcome of Annual General Meeting held on August 16, 2008.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divi_Outcomeofagm_18082008.zip target=NEW> For more details click here.</a>","18-Aug-2008 09:49:00","2008-08-18 09:49:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release, titled ""Divi's Labs PAT for Q1 grows by 45% to Rs.94 crores"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). <a href=/content/corporate/Divis_PR_26072008.zip target=NEW> For more details click here.</a>","26-Jul-2008 18:03:00","2008-07-26 18:03:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Quarter ended, 30-JUN-2008","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 26607 lacs for quarter ending on 30-JUN-2008 against Rs. 22807 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 9648 lacs for the quarter ending on 30-JUN-2008 against Rs. 6728 lacs for the quarter ending on 30-JUN-2007.","26-Jul-2008 17:43:00","2008-07-26 17:43:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-JUN-2008","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 26358 lacs for quarter ending on 30-JUN-2008 against Rs. 22672 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 9433 lacs for the quarter ending on 30-JUN-2008 against Rs. 6490 lacs for the quarter ending on 30-JUN-2007.","26-Jul-2008 17:42:00","2008-07-26 17:42:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Allotment of Equity Shares","Divi'S Laboratories Limited has informed the Exchange that Compensation Committee of Board of Directors in its meeting held on July 26, 2008 made the allotment of 51175 equity shares of Rs.2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64724125 equity shares from 64672950 equity shares of face value Rs.2/- each.","26-Jul-2008 17:19:00","2008-07-26 17:19:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi'S Laboratories Limited has informed the Exchange that the Share Transfer Books of the Company will remain closed from June 28, 2008 to July 04, 2008 (both days inclusive) for the purpose of the Annual General Meeting of the company scheduled to be held on August 16, 2008 and payment of dividend, if declared at the ensuing Annual General Meeting.","12-Jun-2008 16:05:00","2008-06-12 16:05:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors at their meeting held on June 07, 2008 has recommended a dividend of 200% on equity shares for the year ended March 31, 2008.","09-Jun-2008 09:40:00","2008-06-09 09:40:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release, titled ""Divi's Labs PAT for FY08 grows by 87% to Rs.348 crores"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).  <a href=/content/corporate/Divi_PR_09062008.zip target=NEW> For more details click here.</a>","09-Jun-2008 09:38:00","2008-06-09 09:38:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Year ended, 31-MAR-2008","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 103319 lacs for year ending on 31-MAR-2008 against Rs. 72442 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 35356 lacs for the year ending on 31-MAR-2008 against Rs. 19174 lacs for the year ending on 31-MAR-2007.","09-Jun-2008 09:12:00","2008-06-09 09:12:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Year ended, 31-MAR-2008","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 103283 lacs for year ending on 31-MAR-2008 against Rs. 72458 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 34760 lacs for the year ending on 31-MAR-2008 against Rs. 18586 lacs for the year ending on 31-MAR-2007.","09-Jun-2008 09:11:00","2008-06-09 09:11:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Quarter ended, 31-MAR-2008","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 27814 lacs for quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 9268 lacs for the quarter ending on 31-MAR-2008.","09-Jun-2008 09:10:00","2008-06-09 09:10:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Quarter ended, 31-MAR-2008","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 27839 lacs for quarter ending on 31-MAR-2008 against Rs. 25259 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 9437 lacs for the quarter ending on 31-MAR-2008 against Rs. 10098 lacs for the quarter ending on 31-MAR-2007.","09-Jun-2008 09:09:00","2008-06-09 09:09:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Divi'S Laboratories Limited has submitted to the Exchange two annual disclosure statements of employees and Directors of the Company for the year ended March 31, 2008 pursuant to the Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 2002. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DIVI_REg_30042008.zip target=NEW> For more details click here.</a>","30-Apr-2008 20:18:00","2008-04-30 20:18:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations 2002, the following, who are Director ,have intimated the Company, stating that their holdings have changed consequent to the allotment of equity shares under Employee Stock Option Scheme 2006 of the Company: (1) Name of the Director : Mr N V Ramana - Executive Director; No. of Shares allotted: 59175; Date of allotment :- 19.04.2008; Balance holding : 329425; (2) Name of the Director : Dr P Gundu Rao - Director (R&D); No. of Shares allotted: 3550; Date of allotment :- 19.04.2008; Balance holding : 3635"".","28-Apr-2008 10:16:00","2008-04-28 10:16:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi'S Laboratories Limited has informed the Exchange that : ""Compensation Committee of Board of Directors in its meeting held on 19th April 2008 made the allotment of 115850 equity shares of Rs. 2/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 64672950 equity shares from 64557100 equity shares of face value Rs. 2/- each.""","21-Apr-2008 12:32:00","2008-04-21 12:32:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Publish Audited Results","Divi'S Laboratories Limited has informed the Exchange that ""The Audited Financial Results of the Company for the entire financial year 2007-2008 shall be considered and published by the company within a period of three months from the end of the financial year, i.e. on or before 30th June 2008. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on 31st March, 2008.""","11-Apr-2008 14:41:00","2008-04-11 14:41:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Director / dependent family member of a Director, have intimated the  company on 9th April 2008, stating that they have sold  the equity shares held by them in the Company: (1) Name of the Director/Dependent Family Member : Dr. P Gundu Rao; No. of Shares Sold: 1200; Date of Execution :- 08.04.2008; Balance holding : 85; (2) Name of the Director/Dependent Family Member : Ms P Narmada Rao; No. of Shares Sold: 500; Date of Execution :- 08.04.2008; Balance holding : 25"".","11-Apr-2008 11:11:00","2008-04-11 11:11:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Updates","Divi'S Laboratories Limited has informed the Exchange that ""Divi's Laboratories is glad to announce that it has had a successful inspection by the US-FDA, without any observations, for its Unit-1 at vill. Lingojigudem, Choutuppal Mandal near Hyderabad during this month. The purpose of this inspection was for product pre-approval and general cGMP (Current Good Manufacturing Practices)"".","19-Feb-2008 12:37:00","2008-02-19 12:37:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Director (Projects) of the company has intimated on 11th February 2008, stating that he has received gift of the following equity shares from his relative: (1) Name of the Director - Madhusudana Rao Divi; No. of Shares :- 20000; Date of Execution :- 09.02.2008; Balance holding :- 154500"".","12-Feb-2008 14:45:00","2008-02-12 14:45:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release, titled ""Divi's Labs PAT for Q3 grows by 216% to Rs.99 crores"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divi_PR_28012008.zip target=NEW> For more details click here.</a>","28-Jan-2008 19:00:00","2008-01-28 19:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Quarter ended, 31-DEC-2007","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 28413 lacs for quarter ending on 31-DEC-2007 against Rs. 14951 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 9906 lacs for the quarter ending on 31-DEC-2007 against Rs. 3139 lacs for the quarter ending on 31-DEC-2006.","28-Jan-2008 17:26:00","2008-01-28 17:26:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Quarter ended, 31-DEC-2007","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 28422 lacs for quarter ending on 31-DEC-2007 against Rs. 14962 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 10066 lacs for the quarter ending on 31-DEC-2007 against Rs. 3273 lacs for the quarter ending on 31-DEC-2006.","28-Jan-2008 17:24:00","2008-01-28 17:24:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Executive Director of the company has intimated on 10th December 2007, stating that he has gifted to his relative the following equity shares held by him in the company: (1) Name of the Director - N V Ramana; No. of Shares Gifted - 27340; Date of Execution - 10.12.2007; Balance holding - 20000"".","14-Dec-2007 11:22:00","2007-12-14 11:22:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release which is as follows: ""Divi's laboratories has earned a PAT of Rs.91 crores on consolidated basis for the second quarter ending 30th September, 2007. Total income for the quarter grew by 48% to Rs.245 crores. For the corresponding quarter of last year, the company earned a PAT of Rs.30 crores on a total income of Rs.165 crores. For the current half-year, Divi's earned a PAT of Rs.156 crores on income of Rs.475 crores as against a PAT of Rs.56 crores and income of Rs.330 crores during the corresponding previous half-year"".","27-Oct-2007 17:46:00","2007-10-27 17:46:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Half Yearly ended, 30-SEP-2007","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2007 as follows: Net Sales of Rs. 47056 lacs for half year ending on 30-SEP-2007 against Rs. 32241.27 lacs for the half year ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 15586 lacs for the half year ending on 30-SEP-2007 against Rs. 5553.91 lacs for the half year ending on 30-SEP-2006.","27-Oct-2007 17:34:00","2007-10-27 17:34:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-SEP-2007","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 24384 lacs for quarter ending on 30-SEP-2007 against Rs. 16172.15 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 9097 lacs for the quarter ending on 30-SEP-2007 against Rs. 2990.5 lacs for the quarter ending on 30-SEP-2006.","27-Oct-2007 17:32:00","2007-10-27 17:32:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Quarter ended, 30-SEP-2007","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 24251 lacs for quarter ending on 30-SEP-2007 against Rs. 16136.61 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 9125 lacs for the quarter ending on 30-SEP-2007 against Rs. 3128.22 lacs for the quarter ending on 30-SEP-2006.","27-Oct-2007 17:28:00","2007-10-27 17:28:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Outcome of AGM","Divi'S Laboratories Limited has informed the Exchange that the members of the Company passed the following resolution at the Annual General Meeting held on September 3, 2007. 1) Confirmed Interim dividend paid at Rs. 10/- each for equity shares as Dividend for the year. 2)Re-appointment of Dr. P. Gundu Rao, as Director liable to retire by rotation. 3) Re-appointment of Dr. K. Satyanarayana, as Director liable to retire by rotation. 4) Re-appointment of Mr. Kiran S. Divi, as Director liable to retire by rotation. 5) Re-appointment of M/s. P.V.R.K. Nageswara Rao & Co., Chartered Accountants , as Statutory Auditors of the Company to hold office till the conclusion of next AGM.","03-Sep-2007 13:19:00","2007-09-03 13:19:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release titled ""Divi's Labs PAT for Q1 grows by 153% to Rs.65 crores"". which is has follows ""Divi's Laboratories has earned a PAT of Rs.65 crores on a consolidated basis for the quarter ending 30th June, 2007. The total income grew by 39% to Rs.230 crores. An amount of Rs.2 crores has been charged as expense during the year on account of Stock options. For the first quarter of last year, it earned a PAT of Rs.26 crores on a total income of Rs.165 crores during the last year"".","30-Jul-2007 17:42:00","2007-07-30 17:42:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-JUN-2007","Divi's Laboratories Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 22672 lacs for quarter ending on 30-JUN-2007 against Rs. 16069.12 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 6490 lacs for the quarter ending on 30-JUN-2007 against Rs. 2563.41 lacs for the quarter ending on 30-JUN-2006.","30-Jul-2007 17:26:00","2007-07-30 17:26:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Standalone Results Update, Quarter ended, 30-JUN-2007","Divi's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 22807 lacs for quarter ending on 30-JUN-2007 against Rs. 16083.9 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 6728 lacs for the quarter ending on 30-JUN-2007 against Rs. 2674.5 lacs for the quarter ending on 30-JUN-2006.","30-Jul-2007 17:25:00","2007-07-30 17:25:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi'S Laboratories Limited has informed the Exchange that the share transfer books of the company will be closed from August 10, 2007 to August 13, 2007 (both days inclusive) for: i) Sub-division of Equity Shares of the Company to Rs.2/- per share from the existing Face Value of Rs.10/- per share and ii) Annual General Meeting of the Company scheduled to be held on September 03, 2007.","10-Jul-2007 19:05:00","2007-07-10 19:05:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results of Postal Ballot","Divi'S Laboratories Limited has submitted to the Exchange a copy of the report issued by Mr.V.Bhasakara Rao, Company Secretary in Practice, Scrutinizer for the Postal Ballot conducted in pursuance of Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution through Postal Ballot) Rules 2001, in respect of (i) sub division of the equity shares of Rs.10/- each of the Company into 5 (Five) shares of Rs.2/- each and (ii) reappointment and enhancement of remuneration payable to Dr P Gundu Rao, Director (R&D) of the Company. Basing on the report submitted by the Scrutinizer, Mr. N V Ramana, Executive Director has declared on July 09, 2007 that the resolutions are passed with requisite majority. The company has further informed the Exchange that the members of the company have approved the (i) sub division of the Equity shares of the Company to Rs.2/- per share from the existing Face Value of Rs.10/- per share and  (ii) reappointment and enhancement of remuneration payable to Dr P Gundu Rao, Director (R&D) of the Company. The details of the results of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DivisLab_ResultsPB.zip target=NEW> For more details click here.</a>","10-Jul-2007 10:00:00","2007-07-10 10:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a dependent family member of a Director has intimated the Company on 27th June 2007, stating that she has sold the equity shares held by her in the company: (1) Name of the Dependent Family Member - P Narmada Rao; No. of Shares Sold - 500; Date of Execution - 22.06.2007; Balance holding - 105"".","02-Jul-2007 16:23:00","2007-07-02 16:23:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a Director have intimated the company on 27th June 2007, stating that he has sold the equity shares held by him in the company: (1) Name of the Director - Dr P Gundu Rao; No. of Shares sold - 500; Date of Execution - 22.06.2007; Balance holding - 257"".","02-Jul-2007 16:21:00","2007-07-02 16:21:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a dependent family member of a Director has intimated the Company on 18th June 2007, stating that she has sold the equity shares held by her in the company : (1) Name of the Dependent Family Member - P Narmada Rao; No. of Shares Sold - 95; Date of Execution - 14.06.2007; Balance holding - 605"".","22-Jun-2007 15:43:00","2007-06-22 15:43:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insiders, who are Directors have intimated the company on 18th June 2007, stating that they have sold the equity shares held by them in the company : (1) Name of the Director - Dr P Gundu Rao; No. of Shares sold - 91; Date of Execution - 14.06.2007; Balance holding - 757. (2) Name of the Director - G V Rao; No. of Shares sold - 200; Date of Execution - 13.06.2007; Balance holding - 200"".","22-Jun-2007 15:33:00","2007-06-22 15:33:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is dependent family member of a Director has intimated on 1st June 2007, stating that she has sold the equity shares held by her in the company : (1) Name of the Dependent Family Member - P Narmada Rao; No. of Shares Sold - 300; Date of Execution - 31.05.2007; Balance holding - 700"".","08-Jun-2007 13:15:00","2007-06-08 13:15:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot","Divi'S Laboratories Limited has informed the Exchange that pursuant to Section 192A (2) of the Companies Act, 1956, read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001, the company is seeking approval of the shareholders to pass the resolutions as Special Resolutions by way of Postal Ballot. The Company has appointed Mr. V. Bhaskara Rao, Practising Company Secretary as Scrutinizer for conducting the Postal Ballot process in a fair and transparent manner. The duly completed postal ballot form should reach the Scrutinizer not later than the close of working hours on July 06, 2007. The results of postal ballot will be announced by a Director of the Company on July 09, 2007. A copy of the Notice of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DivisLab_PBNotice.zip target=NEW> For more details click here.</a>","06-Jun-2007 12:38:00","2007-06-06 12:38:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release titled ""Divi's Labs PAT for FY07 grows by 167% to Rs.186 crores"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/divi_PR_230507.zip target=NEW> For more details click here.</a>","23-May-2007 18:37:00","2007-05-23 18:37:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Split of equity shares","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company, at their meeting held on May 23, 2007, have recommended split of Equity Shares from face value of Rs 10/- each to RS 2/- each, subject to approval of members. The Board decided to take the shareholders approval through postal Ballot and approved the notice along with explanatory statement to be sent to shareholders.","23-May-2007 18:22:00","2007-05-23 18:22:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results of Postal Ballot","Divi'S Laboratories Limited has submitted to the Exchange a copy of the report issued by Mr.V.Bhasakara Rao, Company Secretary in Practice, Scrutinizer for the Postal Ballot conducted in pursuance of Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution through Postal Ballot) Rules 2001, in respect of four Ordinary Resolutions to increase the remuneration payable to Whole-time Directors of the company in accordance with the provisions of Sections 198, 269, 309, 310, 314 and other applicable provisions, if any read along with Schedule XIII of the Companies Act, 1956. Basing on the report submitted by the Scrutinizer, Dr P Gundu Rao, Director (R & D) has declared on May 19, 2007 that the resolutions are passed with requisite majority. The company has further informed the Exchange that the members of the company have approved increase of remuneration payable to whole-time Directors of the company, in accordance with the provisions of Sections 198, 269, 309, 310, 314 and other applicable provisions, if any read along with schedule XIII of the Companies Act, 1956. The details of the results of the Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/divi_PBres_210507.zip target=NEW> For more details click here.</a>","21-May-2007 11:35:00","2007-05-21 11:35:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is Director (R&D) of the company has intimated on 14th May 2007, stating that he has gifted to his relative the following equity shares held by him in the company : 1) Name of the Director - Dr P Gundu Rao; No. of Shares Gifted - 1000; Date of Execution - 14.05.2007; Balance holding - 848"".","16-May-2007 10:39:00","2007-05-16 10:39:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee has intimated the company on 7th May 2007, stating that he has gifted to his relative the following equity shares held by him in the company : 1) Name of Designated Employee - S Chandra Divi; No. of Shares Gifted - 1556; Date of Execution - 05.05.2007; Balance holding - 1348"".","08-May-2007 19:04:00","2007-05-08 19:04:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee has intimated the company on 26th April 2007, stating that he has gifted to his relative the following equity shares held by him in the company : 1) Name of Designated Employee - S Devendra Rao; No. of Shares Sold - 276; Date of Execution - 25.04.2007; Balance holding - 2164"".","05-May-2007 14:51:00","2007-05-05 14:51:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that ""The 'purchase' by the Designated employees in the Annual Disclosure Statement submitted by the Company includes allotment of shares under ESOP Scheme besides the other purchases"".","04-May-2007 15:31:00","2007-05-04 15:31:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has submitted to the Exchange a copy of annual disclosure statement of Directors of the Company for the year ended March 31, 2007 pursuant to the Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 2002. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/divi_reg_030507.zip target=NEW> For more details click here.</a>","03-May-2007 20:15:00","2007-05-03 20:15:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has submitted to the Exchange a copy of two annual disclosure statements of employees and Directors of the Company for the year ended March 31, 2007 pursuant to the Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 2002. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divis_Disclosure30042007.zip target=NEW> For more details click here.</a>","30-Apr-2007 20:37:00","2007-04-30 20:37:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee, has intimated the company on 26th April 2007, stating that he has gifted to his relative the following equity shares held by him in the Company: (1) Name of Designated Employee:- Mr. S Devendra Rao; No. of Shares Sold:- 276;  Date of Execution:- 25.04.2007; Balance holding:- 2164"".","27-Apr-2007 12:14:00","2007-04-27 12:14:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is a designated employee, has intimated the company on 20th April 2007, stating that he has sold the equity shares held by him in the Company: (1) Name of Designated Employee:- Mr. B Vara Prasad; No. of Shares Sold:- 670;  Date of Execution:- 17.04.2007; Balance holding:- 2"".","24-Apr-2007 10:32:00","2007-04-24 10:32:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Publish Audited Results","Divi'S Laboratories Limited has informed the Exchange that ""The Audited Financial Results of the Company for the entire financial year 2006-2007 shall be considered and published by the Company within a period of three months from the end of the financial year, i.e. on or before 30th June 2007. Hence the Company is not considering the un-audited financial results for the last quarter of the financial year ended on 31st March 2007"".","17-Apr-2007 11:48:00","2007-04-17 11:48:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that as per the SEBI (Prohibition of Insider Trading) Regulations 2002, the insiders (as per list enclosed), who are designated employees, have intimated the Company, stating that their holdings have changed consequent to the allotment of shares under Employee Stock Option Scheme 2006 of the company. The details of the the list shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/divi_reg_300307.zip target=NEW> For more details click here.</a>","30-Mar-2007 19:41:00","2007-03-30 19:41:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Outcome of meeting","Divi'S Laboratories Limited has informed the Exchange that: ""Compensation Committee of Board of Directors in its meeting held on 17th March 2007 made the allotment of 92720 equity shares of Rs.10/- each to the employees under ESOP 2006 Scheme of the company. Consequent to the above allotment, the paid up share capital of the company will get increased to 12911420 equity shares from 12818700 equity shares"".","19-Mar-2007 09:35:00","2007-03-19 09:35:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Outcome of Board Meeting","Divi'S Laboratories Limited has informed the Exchange that ""Board of Directors in its meeting held on 17th March 2007 declared an interim dividend @ 100% (Rs.10/- per share) on Equity Capital of the Company for the financial year 2006-07 to all the Equity shareholders whose names appear in the Register of Members of the Company on 26th March 2007 being the record date fixed for the purpose of payment of aforesaid dividend"".","19-Mar-2007 09:31:00","2007-03-19 09:31:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Meeting Re-scheduled","Divi'S Laboratories Limited had informed the Exchange regarding Compensation Committee meeting scheduled to be held on March 15, 2007. The company has now informed the Exchange that the meeting of the Compensation Committee of the Company has been postponed to March 17, 2007, to allot the equity shares to employees in pursuance of the ESOP 2006.","12-Mar-2007 10:36:00","2007-03-12 10:36:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Notice of  Meeting","Divi'S Laboratories Limited has informed the Exchange that a meeting of the Compensation Committee is scheduled to be held on 15th March 2007 to allot the equity shares to employees in pursuance of the ESOP 2006.","07-Mar-2007 13:21:00","2007-03-07 13:21:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that: ""As per the SEBI (Prohibition of Insider Trading) Regulations, 2002, the following insider, who is designated employee, has intimated the company on 1st March 2007, stating that he has acquired  the equity shares of the Company : (1) Name of Designated Employee :- Mr. P Srinivas Rao; No. of Shares acquired :- 4500;  Mode of Acquisition :- Market; Market Price :- Rs.2990; Total holding - 18991"".","05-Mar-2007 14:48:00","2007-03-05 14:48:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that ""as per the SEBI (Prohibition of Insider Trading) Regulation, 2002, the following insider, who is designated employee, have intimated the company on 3rd February 2007, stating that they he have acquired on 31st January 2007 the shares of the Company : (1) Name of Designated Employee :- Mr. S. Rama Krishna; No. of Shares acquired :- 1000;  Mode of Acquisition :- Market; Market Price :- Rs. 3170; Total holding - 5501"".","06-Feb-2007 12:07:00","2007-02-06 12:07:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release, titled ""Divi's Labs Q3 total income grows by 38% to Rs.152 crores"". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divilab_PR_27012007.zip target=NEW> For more details click here.</a>","27-Jan-2007 18:36:00","2007-01-27 18:36:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg7(3)&Reg13(6)of SEBI Subs. Acq &Takeovers&Insider Trading","Divi'S Laboratories Limited has informed the Exchange that: ""The Oppenheimer Funds Inc. A/C Oppenheimer Developing Markets Fund, which holds more than 5% shares in the company, has sold 152312 No. of shares amounting to 1.19% of total shareholding, which has resulted in shareholding falling below 5%. As per Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and in terms of regulations 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992, company has to disclose purchase or sale aggregating 2% or more of total share capital of the company even if such change results in shareholding falling below 5%. In this case, though the change does not exceed 2% of total shareholding, we are intimating the same for your information and records. Name of Shareholder - Oppenheimer Funds Inc. A/C Oppenheimer Developing Markets Fund; No & % of shares Sold - 152312 (1.19%); Shareholding before Sale % - 641907 (5.01%); Shareholding after Sale % - 489595 (3.82%)"".","04-Jan-2007 15:54:00","2007-01-04 15:54:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that ""as per the SEBI (Prohibition of Insider Trading) Regulation, 2002, the following insiders, who are dependent family members of designated employees have intimated the company, stating that they have sold the equity shares held by them in the company: (01) Name of Dependent Family Member : M. Jyothi; No. of Shares Sold - 350;  Date of Execution : 24.11.2006. Balance holding - 525. (02) Name of Dependent Family Member : M. Jyothi; No. of Shares Sold - 325;  Date of Execution : 27.11.2006. Balance holding - 200. (03) Name of Dependent Family Member : L R Kishori; No. of Shares Sold - 3314;  Date of Execution : 01.12.2006. Balance holding - Nil.""","04-Dec-2006 09:53:00","2006-12-04 09:53:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Miscellaneous","Divi'S Laboratories Limited has informed the Exchange that it has had a successful inspection by the US-FDA, without any observations, for its Unit-2 (comprising both EOU and SEZ Units) at village Chippada, Bheemunipatnam Mandal near Visakhapatnam during this month. The purpose of this inspection was for product pre-approval and general cGMP (Current Good Manufacturing Practices).","30-Nov-2006 17:20:00","2006-11-30 17:20:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","News Verification","News Verification : The media had reports that Divi's Laboratories Limited may announce bonus or stock split. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Divi's Laboratories Limited has vide its letter inter-alia stated, ""We wish to inform you that the Company has no proposal to announce any bonus or stock split of shares. If there were any such proposal, the Company would keep the Stock Exchanges informed.""","30-Nov-2006 15:23:00","2006-11-30 15:23:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that the following insiders, who is a dependent family member of the designated employee has intimated the Company on November 20, 2006, stating that she has sold the equity shares held by her in the company as follows :- 1) Name of Dependent Family Member : M. Jyothi; No. of Shares Sold - 625;  Date of Execution : November 17, 2006. Balance holding - 875.","23-Nov-2006 11:49:00","2006-11-23 11:49:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release titled ""Divi's Labs Q2 total income grows by 97% to Rs.165 crores; Divi's SEZ Unit commences commercial operations"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Divis_301006.zip target=NEW> For more details click here.</a>","30-Oct-2006 10:02:00","2006-10-30 10:02:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that the following insiders, who are designated employees have intimated the Company on October 23, 2006, stating that they have acquired on October 18, 2006 the equity shares of the company as follows :- 1) Name of Designated Employee : Mr. P. Srinivas Rao; No. of Shares acquired - 4000; Mode of Acquisition - Market; Market Price - Rs.2350; Total holding - 14576. 2) Name of Designated Employee : Mr. S. Rama Krishna; No. of Shares acquired - 1000; Mode of Acquisition - Market; Market Price - Rs.2355; Total holding - 4501.","27-Oct-2006 11:21:00","2006-10-27 11:21:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Appointment of Company Secretary and Compliance Officer","Divi's Laboratories Limited has informed the Exchange that the company has appointed Ms P V Lakshmi Rajani as the Company Secretary and compliance officer of the company who has joined the organization on September 13, 2006.","29-Sep-2006 17:33:00","2006-09-29 17:33:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Resignation","Divi'S Laboratories Limited has informed the Exchange that Mr. A. Nagaraj Kumar, Company Secretary and Compliance Officer of the Company has left the services of the company w.e.f. September 04, 2006.","20-Sep-2006 16:15:00","2006-09-20 16:15:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Outcome of AGM","Divi'S Laboratories Limited has informed the Exchange that the members of the Company passed the following resolution at the AGM held on September 02,2006 : 1) Approval for payment of dividend at Rs.10 for each equity share. 2) Re-appointment of Mr. S Vasudev, as Director liable to retire by rotation. 3) Re-appointment of Mr. Madhusudana Rao Divi, as Director liable to retire by rotation. 4) Re-appointment of Dr. G Suresh Kumar, as Director liable to retire by rotation. 5) Re-appointment of M/s. P.V.R.K. Nageswara Rao & Co., Charetred Accountants, as Statutory Auditors of the Company to hold office till the conclusion of next AGM. 6) Re-appointment of Sri Madhusudana Rao Divi as Director (Projects) and fixation of his remuneration. 7) Re-appointment of Kiran S. Divi as Director (Business Development) and fixation of his remuneration. 8) Revision of remuneration to Mr. N. V. Ramana, Executive Director. 9) Revision of remuneration to Dr. P. Gundu Rao, Director (R&D). 10) Noting of Postal Ballot results declared on March 03,2006 for issue of ESOPs. 11) Noting of certificates issued by statutory auditors in compliance with SEBI (ESOP&ESOS) Guidelines.","04-Sep-2006 00:00:00","2006-09-04 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","AGM/Book Closure","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors in their meeting held on July 31,2006, decided to close the share transfer books of the company from August 25,2006 to September 01,2006 (both days inclusive) for payment of final dividend. Further, the annual general meeting of the Company is scheduled to be held on September 02,2006.","08-Aug-2006 00:00:00","2006-08-08 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release dated July 31,2006, titled ""Divi's Labs Q1 total income grows by 142% at Rs.165 crores"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","31-Jul-2006 00:00:00","2006-07-31 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi'S Laboratories Limited has informed the Exchange that the Board of Directors at their meeting held on June 17,2006 have recommended a dividend of 100% on equity shares of Rs.10 each for the year ended March 31,2006.","19-Jun-2006 00:00:00","2006-06-19 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release titled ""Divi's Laboratories earns a total income of Rs.392 crores in FY06"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","19-Jun-2006 00:00:00","2006-06-19 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Miscellaneous","Divi'S Laboratories Limited has informed the Exchange that the company has received letter of approval from Ministry of Commerce, Government of India, for setting up and development of a sector specific Special Economic Zone for pharmaceutical ingredients at Chippada, Bheemunipatnam. The details of land have also been notified in the Gezetee of India, Extraordinary on May 16,2006.","23-May-2006 00:00:00","2006-05-23 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Divi'S Laboratories Limited has informed the Exchange about two annual disclosure statements of employees and Directors of the Company for the year ended March 31, 2006.  The details of the same are available at the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server ( /Common/CorporateAnnouncements).","02-May-2006 00:00:00","2006-05-02 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","News Verification","News Verification : The media had reports that Divi's Laboratories Limited may consider a bonus issue and also a stock split. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Divi's Laboratories Limited has vide its letter inter-alia stated, ""We wish to clarify that the company has no proposal for stock split or bonus issue.""","02-May-2006 00:00:00","2006-05-02 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Voluntary Delisting","Divi'S Laboratories Limited has informed the Exchange that at the request of the company for voluntary de-listing of its equity shares from the Hyderabad Stock Exchange, the equity shares of the company stand de-listed from The Hyderabad Stock Exchange Limited, Hyderabad w.e.f March 29,2006. Further, the company has issued a press release dated March 29,2006 regarding the same, details of which shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ","29-Mar-2006 00:00:00","2006-03-29 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Grant of Stock Options","Divi'S Laboratories Limited has informed the Exchange that the Compensation Committee of the Company at its meeting held on March 13, 2006 have granted 4,64,920 employee stock options of Rs.10/- each to the eligible employees of the Company under the ESOP 2006.","14-Mar-2006 00:00:00","2006-03-14 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Miscellaneous","Divi'S Laboratories Limited has informed the Exchange that the Company had, during May 2005, signed a multi-year agreement with an MNC Company in USA for supply of a speciality ingredient for which the Company is setting a Plant with an investment of Rs.30 crores at Visakhapatnam. Due to some developments at its end, the MNC Customer has asked the company to stop further implementation of the plant. The MNC Customer would decide further plan of action in due course.","08-Mar-2006 00:00:00","2006-03-08 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results of Postal Ballot","Divi'S Laboratories Limited has submitted to the Exchange a copy of the report issued by Mr. V Bhasakara Rao, Company Secretary in Practice, Scrutinizer for the Postal Ballot conducted in pursuance of Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution through Postal Ballot) rules 2001, in respect of the Special Resolution to issue equity shares by way of ESOP under the Guidelines in accordance with section 81(1A) of the Companies Act, 1956.  Basing on the report submitted by the Scrutinizer, Sri N. V. Ramana, Executive Director has declared on this day that the resolution is passed by 99.95% majority.  The Company has further informed that the members of the Company has approved for issue of equity shares by way of ESOP under the Guidelines in accordance with section 81(1A) of the Companies Act, 1956. A copy of report shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","06-Mar-2006 00:00:00","2006-03-06 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Delisting of shares","Divi'S Laboratories Limited has informed the Exchange that the members of the company in the AGM held on August 22, 2003, resolved pursuant to the SEBI (Delisting of Securities) Guidelines, 2003 to delist the equity shares of Divi's Laboratories Limited (the Company) from Hyderabad Stock Exchange. The Company proposes to delist equity share of the Company from Hyderabad Stock Exchange effective from March 01, 2006. The Company further confirm that the Company continues to be listed on National Stock Exchange even after delisting from the Hyderabad Stock Exchange.","06-Feb-2006 00:00:00","2006-02-06 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Postal Ballot","Divi'S Laboratories Limited has informed the Exchange that the BoDs in their meeting held on January 30, 2006 decided to introduce an Employee Stock Option Scheme (ESOP) for its employees in accordance with SEBI Guidelines. Board has decided to grant options not more that 5,00,000 equity shares of Rs.10/- of the Company. Board has decided to seek shareholders approval by postal ballot and accordingly notice pursuant to section 192(a) of the Companies Act 1956 along with explanatory statement under section 173 (2) of the Companies Act 1956 is being sent to shareholders for passing of resolution as special resolution. The Company has appointed Mr. V.Bhaskara Rao, Practising Company Secretary, as the scrutinizer for conducting the Postal Ballot process in a fair and transparent manner. The duly completed Postal Ballot form should reach the Scrutinizer not later than the close of working hours on March 02, 2006 and the result of the Postal Ballot will be announced by a Director on March 03, 2006. A copy of the postal ballot notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","02-Feb-2006 00:00:00","2006-02-02 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a Press Release titled 'Divi's Laboratories earns a Net of Rs.19 crores on an Income of Rs.110 crores in Q3'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","31-Jan-2006 00:00:00","2006-01-31 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Divi'S Laboratories Limited has informed the Exchange that Reliance Tax Saver (ELSS) Fund - Scheme of Reliance Mutual Fund has acquired 16,618 shares aggregating to 0.13% of the total paid up capital of Divi's Laboratories Ltd. on January 04, 2006. The mode of acquisition is Market purchase and the shareholding of Reliance Tax Saver (ELSS) Fund - Scheme of Reliance Mutual Fund after the said acquisition is as follows: - Reliance Mutual Fund holds 9,07,575 shares (7.080%) and Portfolio Management Scheme holds 400 shares (0.003%). The aggregate shareholding of Reliance Tax Saver (ELSS) Fund - Scheme of Reliance Mutual Fund after the said acquisition is 9,07,975 shares aggregating to 7.083% of the total paid up capital of Divi's Laboratories Ltd.","13-Jan-2006 00:00:00","2006-01-13 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Change in Company Secretary","Divi'S Laboratories Limited has informed the Exchange that Mr. A Narendra resigned as Company Secretary of the Company. Further, Mr. A Nagaraj Kumar has been appointed as Company Secretary of the Company with effect from November 15, 2005.","16-Nov-2005 00:00:00","2005-11-16 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disc under Reg Subs Acq &Takeover & SEBI Insider Trading Reg","Divi'S Laboratories Limited has informed the Exchange that they have received intimation from Reliance Capital Asset Management Limited regarding the acquisition of shares of Divi's Laboratories Limited by Reliance Vision Fund - Scheme of Reliance Mutual Fund and Reliance Portfolio Management. The details are as follows: Reliance Mutual Fund Scheme has acquired 29,847 shares aggregating to 0.233% of the total paid up capital of Divis Laboratories Ltd. on September 27, 2005. The mode of acquisition is Open Market purchase and the consolidated shareholding of Reliance Vision Fund - Scheme of Reliance Mutual Fund and Reliance Portfolio Management after the said acquisition is 6,51,837 shares aggregating to 5.085% of the total paid up capital of Divis Laboratories Ltd.","04-Oct-2005 00:00:00","2005-10-04 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Proceedings of AGM","Divi'S Laboratories Limited has submitted to the Exchange a copy of the Proceedings of the AGM of the Company for the FY 2004-05, held on August 22, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","03-Oct-2005 00:00:00","2005-10-03 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.7(1) of SEBI (Substantial Acq of shares &Takeovers),1997","Reliance Capital Asset Management Ltd. has informed the Exchange that Reliance Vision Fund - Scheme of Reliance Mutual Fund and Reliance Portfolio Management(Acquirer and PAC with acquirer) has acquired shares of Divis Laboratories Limited as follows: Reliance Mutual Fund Scheme has acquired 29,847 shares aggregating to 0.233% of the total paid up capital of Divis Laboratories Ltd. on September 27, 2005. The mode of acquisition is Open Market purchase and the total shareholding of Reliance Vision Fund - Scheme of Reliance Mutual Fund and Reliance Portfolio Management after the said acquisition is 6,51,837 shares aggregating to 5.085% of the total paid up capital of Divis Laboratories Ltd.","30-Sep-2005 00:00:00","2005-09-30 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Outcome of AGM","Divi'S Laboratories Limited has informed the Exchange that the AGM of the Company was held on August 22, 2005 and all the proposed resolutions were passed with requisite majority, including the resolution for delisting of equity shares from the Hyderabad Stock Exchange. In this connection, the Company has submitted to the Exchange a copy of Chairman's message, delivered to the shareholders at the AGM. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","23-Aug-2005 00:00:00","2005-08-23 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has submitted to the Exchange a copy of the Press Release titled 'Divi's Laboratories earns a total income of Rs.68 Crores in Q1 of FY06'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","05-Aug-2005 00:00:00","2005-08-05 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Date of AGM/Book Closure","Divi'S Laboratories Limited has informed the Exchange that the Share Transfer Books will remain closed from August 13, 2005 to August 22, 2005 (both days inclusive) for the purpose of payment of dividend, subject to the approval of the shareholders in the ensuing AGM Scheduled to be held on August 22, 2005.","16-Jun-2005 00:00:00","2005-06-16 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange regarding a press release titled ""Divi's Laboratories earns a total income of Rs.365 crores in FY05"". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","25-May-2005 00:00:00","2005-05-25 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Dividend","Divi'S Laboratories Limited has informed the Exchange that the Board of Directorsat its meeting held on May 21,2005 has recommend a dividend of 80% on equity shares of Rs. 10/- each for the year ended March 31, 2005 subject to approval of members.","23-May-2005 00:00:00","2005-05-23 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Divi'S Laboratories Limited has informed the Exchange about two annual disclosure statements of employees and Directors of the Company for the year ended March 31, 2005.  The details of the same are available at the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server ( /Common/CorporateAnnouncements).","22-Apr-2005 00:00:00","2005-04-22 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","News Clarification","Divi'S Laboratories Limited has informed the Exchange that CNBC News channel aired a news item on the company on April 05, 2005 stating that ""Divi's Labs has signed a deal for Rs.500 Crores with P&G' and the news channel also mentioned that the company sources have denied having signed any deal"".In this connection,the company has clarified that the comapny has not signed such a deal.","06-Apr-2005 00:00:00","2005-04-06 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Results of Postal Ballot","Divi'S Laboratories Limited has informed the Exchange that the company has received report from Mr.V.Bhaskara Rao, Company Secretary in practice, Scrutiniser for postal ballot conducted in pursuance of Section 192A of the Companies Act,1956 read with the Companies(Passing of resolution through postal ballot)Rules 2001,against of the proposed Special Resolution for  increasing the shareholding limits of Foreign Institutional Investors(FIIs) in the company through Stock Exchanges in India upto 30% of paid up Equity/Preference share capital of the company. Basing on the report submitted by the scrutinizer, Sri N.V.Ramana, Executive Director of the company has declared that the resolution was passed by 99.97% majority.  The details of the result are as follows: a) Total Postal Ballot Forms received - 1253 constituting 8798686 shares of the company(representing 100% of the share capital of the company); b) Invalid postal ballot forms - 35 constituting 4699 shares of the company(representing 0.05% of the share capital of the company); c) Valid postal ballot forms - 1218 constituting 8793987 shares of the company; d) Postal Ballot Forms with assent for the resolution -1191 constituting 8791694 shares of the company(representing 99.97% of the share capital of the company; e) Postal Ballot Forms with dissent for the resolution - 27 constituting 2293 shares of the company(representing 0.03% of the total share capital of the company.","21-Mar-2005 00:00:00","2005-03-21 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Divi'S Laboratories Limited has informed the Exchange that Murali K Divi, Director, has acquired 700,000 equity shares of Divi's Laboratories Limited through inter se transfer from amongst 'promoter group'. The date of acquisition is March 10, 2005 and the mode of acquisition is by way of Gift. The shareholding of Murali K Divi after the said acquisition is 50,78,350 shares of Divi's Laboratories Limited.","15-Mar-2005 00:00:00","2005-03-15 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.7(3) of SEBI (Substantial Acq of shares &Takeovers),1997","Divi'S Laboratories Limited has informed the Exchange that Murali K Divi, Promoter of the Company, has acquired 700,000 shares of Divi's Laboratories Limited on March 10, 2005. The mode of acquisition is by way of Interse Transfer and the shareholding of Murali K Divi after the said acquisition is 50,78,350 shares aggregating 39.62% of the share capital of the Company.","15-Mar-2005 00:00:00","2005-03-15 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.7(1) of SEBI (Substantial Acq of shares &Takeovers),1997","Murali K Divi has informed the Exchange that he has acquired 700,000 shares of Divi's Laboratories Limited from another person in the 'promoter group'. The date of acquisition/date of receipt of intimation of allotment by acquirer is March 10, 2005 and the mode of acquisition is Interse Transfer. The shareholding of Murali K Divi after the said acquisition is 50,78,350 shares aggregating 39.62% of the share capital of Divi's Laboratories Limited.","11-Mar-2005 00:00:00","2005-03-11 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.3(3) of SEBI (Substantial Acq of shares &Takeovers),1997","Murali K Divi has informed the Exchange that that he proposes to acquire 700,000 shares aggregating to 5.46% of the share capital of Divi's Laboratories Limited from Ms. Nilima Divi. The date of the proposed acquisition is March 09, 2005 and the mode of proposed acquisition is by way of gift. The shareholding of Murali K Divi after the proposed acquisition will be 50,78,350 shares aggregating 39.62% of the share capital of Divi's Laboratories Limited.","04-Mar-2005 00:00:00","2005-03-04 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Miscellaneous","Divi'S Laboratories Limited has informed the Exchange that the BODs have considered the increase of the limits of shareholding of Foreign Institutional Investors in the company and approved the same for increasing the existing limits from 24% to 30% of the paid-up share capital of the company. In this connection, the company would be seeking approval of the shareholders of the company by way of postal ballot.","01-Feb-2005 00:00:00","2005-02-01 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Press Release","Divi'S Laboratories Limited has informed the Exchange that the company proposes to issue a press release titled 'Divi's Laboratories achieves Income of Rs.105 crores in Q3'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","28-Jan-2005 00:00:00","2005-01-28 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Reg.7(1) of SEBI (Substantial Acq of shares &Takeovers),1997","Divi'S Laboratories Limited has informed the Exchange that the following investor has crossed the 5% threshold limits as per the details given below : Oppenheimer Funds Inc. c/o HSBC CNC, has acquired (i) 44287 shares aggregating 0.35% of the share capital of Divi's Laboratories Limited between** November 29, 2004 to December 03, 2004, and (ii) 158664 shares aggregating 1.23% of the share capital of Divi's Laboratories Limited between** December 06, 2004 to December 10, 2004. The mode of acquisition is through the Market and the shareholding of Oppenheimer Funds Inc. c/o HSBC CNC after the said acquisition is 819947 shares aggregating 6.39% of the share capital of Divi's Laboratories Limited. [** As per the Beneficiary Position given by the Company's Registrars Viz., Karvy Computershare Pvt. Ltd.]","20-Dec-2004 00:00:00","2004-12-20 00:00:00","-","-","-"
"DIVISLAB","Divi's Laboratories Limited","Disclosure under the SEBI(Prohibition of Insider Trading)","Divi'S Laboratories Limited has informed the Exchange that the following designated employee(s) / dependent family member(s) have intimated the company about their dealings in the equity shares of the company. The details are as follows: 1) YTS Prasad has sold 400 shares. The mode of sale is through market and the date of execution is September 27, 2004. The balance holding is 50 shares.","07-Oct-2004 00:00:00","2004-10-07 00:00:00","-","-","-"